


<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
         xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
    <responseDate>2025-09-09T14:04:17Z</responseDate>
    <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:12406344" metadataPrefix="pmc">https://pmc.ncbi.nlm.nih.gov/api/oai/v1/mh/</request>
    
    <GetRecord>
        <record>
    <header>
    <identifier>oai:pubmedcentral.nih.gov:12406344</identifier>
    <datestamp>2025-09-04</datestamp>
    
        
        <setSpec>subabusetpp</setSpec>
        
    
        
        <setSpec>pmc-open</setSpec>
        
    
</header>
    <metadata>
        
        <article xmlns="https://jats.nlm.nih.gov/ns/archiving/1.4/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.4/ https://jats.nlm.nih.gov/archiving/1.4/xsd/JATS-archivearticle1-4.xsd" article-type="review-article" xml:lang="en" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Subst Abuse Treat Prev Policy</journal-id><journal-id journal-id-type="iso-abbrev">Subst Abuse Treat Prev Policy</journal-id><journal-id journal-id-type="pmc-domain-id">398</journal-id><journal-id journal-id-type="pmc-domain">subabusetpp</journal-id><journal-title-group><journal-title>Substance Abuse Treatment, Prevention, and Policy</journal-title></journal-title-group><issn pub-type="epub">1747-597X</issn><publisher><publisher-name>BMC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC12406344</article-id><article-id pub-id-type="pmcid-ver">PMC12406344.1</article-id><article-id pub-id-type="pmcaid">12406344</article-id><article-id pub-id-type="pmcaiid">12406344</article-id><article-id pub-id-type="pmid">40898330</article-id><article-id pub-id-type="doi">10.1186/s13011-025-00673-7</article-id><article-id pub-id-type="publisher-id">673</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Review</subject></subj-group></article-categories><title-group><article-title>Tobacco and asthma: presenting the world health organization (WHO) tobacco knowledge summary</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Lu</surname><given-names initials="W">Wenying</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Rylance</surname><given-names initials="S">Sarah</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Schotte</surname><given-names initials="K">Kerstin</given-names></name><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Aarsand</surname><given-names initials="R">Rebekka</given-names></name><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Lebedeva</surname><given-names initials="E">Elizaveta</given-names></name><xref ref-type="aff" rid="Aff5">5</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Bill</surname><given-names initials="W">Werner</given-names></name><xref ref-type="aff" rid="Aff6">6</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Han</surname><given-names initials="J">Jing</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Lam</surname><given-names initials="DCL">David CL</given-names></name><xref ref-type="aff" rid="Aff7">7</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Soriano</surname><given-names initials="JB">Joan B.</given-names></name><xref ref-type="aff" rid="Aff8">8</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Yorgancioglu</surname><given-names initials="A">Arzu</given-names></name><xref ref-type="aff" rid="Aff9">9</xref></contrib><contrib contrib-type="author" corresp="yes"><name name-style="western"><surname>Sohal</surname><given-names initials="SS">Sukhwinder Singh</given-names></name><address><email>sukhwinder.sohal@utas.edu.au</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/01nfmeh72</institution-id><institution-id institution-id-type="GRID">grid.1009.8</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 826X</institution-id><institution>Respiratory Translational Research Group, Department of Laboratory Medicine, School of Health Sciences, College of Health and Medicine, </institution><institution>University of Tasmania, </institution></institution-wrap>The Shed Building, 80 Cimitiere Street, Launceston, TAS 7250 Australia </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/01f80g185</institution-id><institution-id institution-id-type="GRID">grid.3575.4</institution-id><institution-id institution-id-type="ISNI">0000 0001 2163 3745</institution-id><institution>Department of Noncommunicable Diseases, Rehabilitation and Disability, </institution><institution>World Health Organization, </institution></institution-wrap>Geneva, Switzerland </aff><aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/01f80g185</institution-id><institution-id institution-id-type="GRID">grid.3575.4</institution-id><institution-id institution-id-type="ISNI">0000 0001 2163 3745</institution-id><institution>Department of Health Promotion, </institution><institution>World Health Organization, </institution></institution-wrap>Geneva, Switzerland </aff><aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/01f80g185</institution-id><institution-id institution-id-type="GRID">grid.3575.4</institution-id><institution-id institution-id-type="ISNI">0000 0001 2163 3745</institution-id><institution>Department of Digital Health and Innovation, </institution><institution>World Health Organization, </institution></institution-wrap>Geneva, Switzerland </aff><aff id="Aff5"><label>5</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/01rz37c55</institution-id><institution-id institution-id-type="GRID">grid.420226.0</institution-id><institution-id institution-id-type="ISNI">0000 0004 0639 2949</institution-id><institution>Tobacco Control Unit, Special Initiative on NCDs and Innovation, </institution><institution>World Health Organization, Regional Office for Europe, </institution></institution-wrap>Copenhagen, Denmark </aff><aff id="Aff6"><label>6</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/00c8n3h65</institution-id><institution-id institution-id-type="GRID">grid.424882.0</institution-id><institution-id institution-id-type="ISNI">0000 0004 0634 2466</institution-id><institution>European Respiratory Society (ERS), </institution></institution-wrap>Lausanne, Switzerland </aff><aff id="Aff7"><label>7</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/02zhqgq86</institution-id><institution-id institution-id-type="GRID">grid.194645.b</institution-id><institution-id institution-id-type="ISNI">0000 0001 2174 2757</institution-id><institution>Department of Medicine, School of Clinical Medicine, </institution><institution>University of Hong Kong, </institution></institution-wrap>Hong Kong SAR, China </aff><aff id="Aff8"><label>8</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/00ca2c886</institution-id><institution-id institution-id-type="GRID">grid.413448.e</institution-id><institution-id institution-id-type="ISNI">0000 0000 9314 1427</institution-id><institution>Servicio de Neumolog&#237;a, Hospital Universitario de la Princesa; Facultad de Medicina, Universidad Aut&#243;noma de Madrid; Centro de Investigaci&#243;n Biom&#233;dica en Red de Enfermedades Respiratorias, </institution><institution>Instituto de Salud Carlos III, all in Madrid, </institution></institution-wrap>Madrid, Spain </aff><aff id="Aff9"><label>9</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/053f2w588</institution-id><institution-id institution-id-type="GRID">grid.411688.2</institution-id><institution-id institution-id-type="ISNI">0000 0004 0595 6052</institution-id><institution>Department of Pulmonology, Medical Faculty, </institution><institution>Celal Bayar University, Global Initiative for Asthma (GINA), </institution></institution-wrap>Manisa, Turkey </aff></contrib-group><pub-date pub-type="epub"><day>2</day><month>9</month><year>2025</year></pub-date><pub-date pub-type="collection"><year>2025</year></pub-date><volume>20</volume><issue-id pub-id-type="pmc-issue-id">479339</issue-id><elocation-id>34</elocation-id><history><date date-type="received"><day>22</day><month>12</month><year>2024</year></date><date date-type="accepted"><day>22</day><month>8</month><year>2025</year></date></history><pub-history><event event-type="pmc-release"><date><day>02</day><month>09</month><year>2025</year></date></event><event event-type="pmc-live"><date><day>04</day><month>09</month><year>2025</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2025-09-04 10:25:45.023"><day>04</day><month>09</month><year>2025</year></date></event></pub-history><permissions><copyright-statement>&#169; The Author(s) 2025</copyright-statement><copyright-year>2025</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbyncndlicense">https://creativecommons.org/licenses/by-nc-nd/4.0/</ali:license_ref><license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article&#8217;s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article&#8217;s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">http://creativecommons.org/licenses/by-nc-nd/4.0/</ext-link>.</license-p></license></permissions><self-uri content-type="pmc-pdf" xlink:href="13011_2025_Article_673.pdf"/><abstract id="Abs1"><p id="Par1">The WHO recently published a Tobacco Knowledge Summary (TKS) which is prepared with the objective to summarize the current evidence on the association between tobacco use and asthma. This is also intended as an advocacy tool to widely include health care professionals in the fight for tobacco control and prevention of tobacco related adverse health effects. This article expands on the evidence outlined in the TKS, providing a more comprehensive and clinically focused analysis, aimed at lung-specialist audience. It emphasizes six key messages aimed at guiding healthcare providers and governments in advocating for the health of people living with asthma and the broader population: (1) Babies born to mothers who smoke have smaller lungs and an increased risk of developing asthma during childhood. Pregnant women should receive targeted support to quit tobacco use. (2) Children exposed to second-hand tobacco smoke have an increased risk of developing asthma. (3) Smoking during adolescence and adulthood increases the risk of developing asthma and exacerbates the condition, as well as causing other lung diseases such as chronic obstructive pulmonary disease (COPD) and lung cancer. (4) For people living with asthma, smoking worsens symptoms and can make treatment with medications less effective. All smokers with asthma should be supported to quit smoking. (5) E-cigarettes, heated tobacco products and other nicotine-delivery devices likely also carry risks. Governments should implement effective tobacco control measures to protect all individuals, including those who are vulnerable. (6) The tobacco and nicotine industries&#8217; aggressive tactics in the marketing of their products specifically target children, adolescents and young adults. Protecting youth from these harmful tactics is a top priority.</p></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Asthma</kwd><kwd>Smoking and vaping</kwd><kwd>Tobacco control</kwd><kwd>Smoking cessation</kwd></kwd-group><funding-group><award-group><funding-source><institution>Clifford Craig Foundation Launceston General Hospital</institution></funding-source><award-id>P202</award-id><principal-award-recipient><name name-style="western"><surname>Sohal</surname><given-names>Sukhwinder Singh</given-names></name></principal-award-recipient></award-group></funding-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#169; BioMed Central Ltd., part of Springer Nature 2025</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>What is asthma?</title><p id="Par2">Asthma is a chronic lung disease affecting people of all ages. It involves inflammation in the airways that causes muscle tightening and narrowing, making it harder to breathe [<xref ref-type="bibr" rid="CR1">1</xref>]. Asthma symptoms include wheezing, shortness of breath, chest tightness and coughing, which vary over time and are provoked by inhaled allergens, upper respiratory infections, unmanaged exercise and exposure to tobacco smoke and pollutants [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR2">2</xref>]. During asthma attacks, the airways constrict further owing to worsening of inflammation in the airways, and this may be life-threatening [<xref ref-type="bibr" rid="CR3">3</xref>] (Fig.&#160;<xref rid="Fig1" ref-type="fig">1</xref>).</p><p id="Par3">
<fig id="Fig1" position="float" orientation="portrait"><label>Fig. 1</label><caption><p>Tobacco smoking and development of asthma. There were 262 million people of asthma globally in 2019, with high rates of mortality and morbidity. The leading risk factor for developing asthma is smoking, including pregnancy, childhood and adolescence exposure. The pathogenesis of asthma involves various factors such as airway inflammation, oxidative stress, epithelial-mesenchymal transition (EMT) mediated airway remodeling. Asthma people often coexist with other conditions such as chronic obstructive pulmonary disease (COPD), which termed as asthma-COPD overlap (ACO), and lung cancer.</p></caption><graphic id="d33e338" position="float" orientation="portrait" xlink:href="13011_2025_673_Fig1_HTML.jpg"/></fig>
</p></sec><sec id="Sec2"><title>Health impact of asthma</title><p id="Par4">Asthma is a major global health concern and the most common chronic condition in children and adolescents, affecting roughly one in 10 children and adolescents, although with great intra- and international variations [<xref ref-type="bibr" rid="CR4">4</xref>]. In 2019, approximately 262&#160;million people were living with asthma [<xref ref-type="bibr" rid="CR5">5</xref>], resulting in 455 000 deaths [<xref ref-type="bibr" rid="CR1">1</xref>]. These fatalities are of serious concern because many of them are preventable. For comparison, the estimate for chronic obstructive pulmonary disease (COPD) is 212&#160;million prevalent cases, but with many more COPD deaths (3.7&#160;million) annually [<xref ref-type="bibr" rid="CR6">6</xref>, <xref ref-type="bibr" rid="CR7">7</xref>].</p><p id="Par5">Asthma brings a substantial burden of disease, including both premature death and reduced quality of life across all age groups in all parts of the world [<xref ref-type="bibr" rid="CR8">8</xref>]. Those with asthma experience notable impacts on their health-related quality of life, including physical activity, social well-being and general health [<xref ref-type="bibr" rid="CR9">9</xref>]. Moreover, the emotional impact of a chronic condition like asthma can affect mental health [<xref ref-type="bibr" rid="CR10">10</xref>]. Severe asthma attacks often require hospitalization because of uncontrolled airway inflammation, presenting additional health risks for patients and comorbidities owing to the increased need for systemic corticosteroids and other treatments, and incurring a high cost for patients them- selves or their health care providers, particularly in low- and middle-income countries where long- term care is limited or unavailable [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR9">9</xref>&#8211;<xref ref-type="bibr" rid="CR11">11</xref>]. The economic impact of asthma includes direct medical costs, indirect costs related to productivity loss, and intangible costs associated with the decreased quality of life and unrealized productivity of persons with poorly controlled asthma [<xref ref-type="bibr" rid="CR9">9</xref>, <xref ref-type="bibr" rid="CR10">10</xref>]. Fear of severe attacks may result in high levels of stress and anxiety among persons with asthma [<xref ref-type="bibr" rid="CR10">10</xref>]. In many countries, poor implementation of prevention strategies and limited access to affordable quality-assured essential asthma medicines result in an unnecessary burden and unnecessary mortality from asthma [<xref ref-type="bibr" rid="CR12">12</xref>].</p></sec><sec id="Sec3"><title>The link between smoking and asthma</title><sec id="Sec4"><title>Smoking and developing asthma</title><p id="Par6">Smoking is the leading cause of preventable pre- mature mortality in the world and causes serious diseases such as chronic respiratory diseases, lung cancer and other cancers [<xref ref-type="bibr" rid="CR13">13</xref>]. Despite having chronic respiratory symptoms, some people with asthma begin and continue smoking, with prevalence rates in persons with asthma being similar to those found in the general population [<xref ref-type="bibr" rid="CR14">14</xref>]. Smoking also places an individual at a significantly increased risk of developing asthma [<xref ref-type="bibr" rid="CR15">15</xref>, <xref ref-type="bibr" rid="CR16">16</xref>], and cross-sectional studies have reported a higher prevalence of asthma among women than men with the same smoke burden, suggesting greater susceptibility among women to this harm [<xref ref-type="bibr" rid="CR17">17</xref>, <xref ref-type="bibr" rid="CR18">18</xref>]. Activation of inflammatory cells in the airways is thought to be responsible for this heightened risk of asthma associated with smoking [<xref ref-type="bibr" rid="CR19">19</xref>, <xref ref-type="bibr" rid="CR20">20</xref>].</p></sec><sec id="Sec5"><title>Second-hand smoke exposure and asthma</title><p id="Par7">Second-hand or third-hand [<xref ref-type="bibr" rid="CR21">21</xref>] smoke or second- hand aerosol exposure from e-cigarettes presents a significant risk for people with asthma, even if they do not smoke themselves [<xref ref-type="bibr" rid="CR22">22</xref>]. Third-hand smoke or third-hand e-vapour [<xref ref-type="bibr" rid="CR23">23</xref>] is the residual tobacco smoke pollutants or e-vapour chemicals that remain on surfaces in the indoor environment, for instance in cushions and carpets, and in the smoker&#8217;s or vaper&#8217;s skin and clothing. Being around smokers can trigger asthma symptoms owing to the numerous harmful substances in second-hand smoke and the aerosol from e-cigarettes [<xref ref-type="bibr" rid="CR24">24</xref>, <xref ref-type="bibr" rid="CR25">25</xref>], and there is a heightened risk of asthma attacks from such exposures [<xref ref-type="bibr" rid="CR10">10</xref>, <xref ref-type="bibr" rid="CR25">25</xref>]. Additionally, exposure to second-hand smoke may interfere with asthma management, making it challenging to control symptoms and maintain optimal lung function de- spite adherence to medications. Parental smoke exposure, when even one parent smokes at home, is associated with harm to children and especially to those with asthma [<xref ref-type="bibr" rid="CR22">22</xref>]. This is especially the case when children are exposed in confined spaces in motor vehicles or the home [<xref ref-type="bibr" rid="CR26">26</xref>], where third-hand smoke exposure is high [<xref ref-type="bibr" rid="CR21">21</xref>]. Early-life exposure to tobacco smoke impairs lung development and increases the risk of respiratory infections, and contributes to long-term respiratory diseases including asthma and COPD [<xref ref-type="bibr" rid="CR25">25</xref>]. Avoiding second-hand smoke exposure is an essential component of the prevention and management of respiratory diseases and especially for asthma [<xref ref-type="bibr" rid="CR25">25</xref>]. Public health policies that provide for 100% smoke-free indoor public places form an essential component of society&#8217;s protection of the welfare of persons with chronic lung diseases, and especially asthma [<xref ref-type="bibr" rid="CR10">10</xref>, <xref ref-type="bibr" rid="CR25">25</xref>]. We have defined different tobacco products in Table&#160;<xref rid="Tab1" ref-type="table">1</xref>.</p><p id="Par8">
<table-wrap id="Tab1" position="float" orientation="portrait"><label>Table 1</label><caption><p>Tobacco definitions</p></caption><table frame="hsides" rules="groups"><tbody><tr><td align="left" colspan="1" rowspan="1">Smoked tobacco product</td><td align="left" colspan="1" rowspan="1">any product made or derived from tobacco which generates smoke. Examples include manufactured cigarettes, roll-your-own tobacco, cigars, shisha (also known as waterpipe), kreteks and bidis</td></tr><tr><td align="left" colspan="1" rowspan="1">Second-hand smoke (SHS)</td><td align="left" colspan="1" rowspan="1">the smoke emitted from the burning end of a cigarette or other tobacco product, usually in combination with the smoke exhaled by the smoker</td></tr><tr><td align="left" colspan="1" rowspan="1">Smokeless tobacco</td><td align="left" colspan="1" rowspan="1">any product that consists of cut, ground, powdered or other tobacco that is intended to be placed in the oral or nasal cavity. Examples include snuff, chewing tobacco, gutka, mishri and snus</td></tr><tr><td align="left" colspan="1" rowspan="1">Electronic nicotine delivery system (ENDS) (also known as e-cigarette or vaper)</td><td align="left" colspan="1" rowspan="1">a device that heats a liquid to create an aerosol that is inhaled by the user, which typically contains nicotine and toxic substances that are harmful to both users and non-users who are exposed to the aerosols second-hand; the liquid is often flavoured</td></tr><tr><td align="left" colspan="1" rowspan="1">Heated tobacco product (HTP)</td><td align="left" colspan="1" rowspan="1">tobacco product that produces aerosols containing nicotine and toxic chemicals when tobacco is heated or when a device containing tobacco is activated. These aerosols are inhaled by users during a process of sucking or smoking involving a device. They contain the highly addictive substance nicotine, as well as non-tobacco additives, and are often flavoured. Some are termed heat-not-burn tobacco, although most do produce smoke</td></tr><tr><td align="left" colspan="1" rowspan="1">Smoke-free policies</td><td align="left" colspan="1" rowspan="1">comprehensive policies that completely ban smoking in all indoor public places, workplaces, public transport and other public places, with no exceptions for designated smoking areas or rooms</td></tr><tr><td align="left" colspan="1" rowspan="1">Third-hand smoke</td><td align="left" colspan="1" rowspan="1">the residual tobacco smoke pollutants that settle and remain on surfaces, such as furniture and carpets, as well as on smoker&#8217;s skin and clothing in indoor environments. It can remain for weeks and even years, and contains nicotine and toxic chemicals, to which children are particularly prone to increased exposure, due to the tendency to touch those surfaces and put objects in their mouth</td></tr><tr><td align="left" colspan="1" rowspan="1">Third-hand aerosol from e-cigarettes</td><td align="left" colspan="1" rowspan="1">the residual aerosol that contains toxic chemicals, which settle and remain on surfaces in indoor environments</td></tr></tbody></table></table-wrap>
</p></sec><sec id="Sec6"><title>Smoke exposure during pregnancy, childhood and adolescence</title><p id="Par9">Smoking during pregnancy affects fetal development with an increased risk of long-term consequences [<xref ref-type="bibr" rid="CR27">27</xref>]. Studies have shown that maternal smoking during pregnancy significantly increases the risk of low birth weight (&lt;&#8201;2500&#160;g) and preterm birth [<xref ref-type="bibr" rid="CR28">28</xref>, <xref ref-type="bibr" rid="CR29">29</xref>]. For pregnant women, exposure to tobacco smoke (either through smoking or through exposure to second-hand smoke) during pregnancy increases asthma risks for their children [<xref ref-type="bibr" rid="CR30">30</xref>], and infants exposed to smoke after birth face higher risks of respiratory infections and the development of asthma [<xref ref-type="bibr" rid="CR31">31</xref>]. Tobacco exposure in utero is also associated with an increased risk of asthma and wheezing in children and adolescents, with the greatest effect being on the incidence of wheezing in children aged&#8201;&#8804;&#8201;2 years [<xref ref-type="bibr" rid="CR32">32</xref>]. Research has shown that maternal smoking during pregnancy is associated with a heightened immune response (called Type 2 immune response) to allergens in neonates [<xref ref-type="bibr" rid="CR33">33</xref>]. Enhanced Type 2 responses are associated with the development of asthma, and nicotine enhances Type 2 activity [<xref ref-type="bibr" rid="CR31">31</xref>].</p><p id="Par10">A study of a large population-based sample of young teenagers has found that asthma and allergic diseases such as rhinitis and hay fever, but not lifetime eczema, were significantly associated with active tobacco smoking, even after control- ling for second-hand smoking [<xref ref-type="bibr" rid="CR17">17</xref>]. Active smoking has been linked to the severity of asthma in both adolescents and adults [<xref ref-type="bibr" rid="CR34">34</xref>]. There is also epidemiological evidence that the effects of active smoking on asthma seen in adolescence persist throughout life [<xref ref-type="bibr" rid="CR34">34</xref>, <xref ref-type="bibr" rid="CR35">35</xref>]. In various industrialized countries, the relationship between tobacco smoking and either the prevalence or the severity of asthma in adolescence is paralleled by the relation to asthma severity in adulthood [<xref ref-type="bibr" rid="CR17">17</xref>]. At the national level, reductions in smoking have been associated with large reductions in asthma incidence and use of health services such as general-practitioner and emergency-room visits and hospitalizations in Finland [<xref ref-type="bibr" rid="CR36">36</xref>].</p></sec><sec id="Sec7"><title>Smoking worsens asthma and increases development of new lung conditions</title><p id="Par11">Smoking exacerbates symptoms and attacks in many asthmatic people, as their lungs are especially sensitive to cigarette smoke [<xref ref-type="bibr" rid="CR10">10</xref>]. In the short term, smoking alongside asthma heightens the risk of asthma attacks while, in the long term, it elevates the chances of developing smoking-related conditions such as emphysema [<xref ref-type="bibr" rid="CR2">2</xref>].</p><p id="Par12">Smoking has been strongly linked to negative clinical outcomes in asthma, including suboptimal asthma control [<xref ref-type="bibr" rid="CR14">14</xref>], accelerated decline in lung function [<xref ref-type="bibr" rid="CR20">20</xref>, <xref ref-type="bibr" rid="CR37">37</xref>, <xref ref-type="bibr" rid="CR38">38</xref>], increased exacerbations [<xref ref-type="bibr" rid="CR39">39</xref>], reduced response to inhaled corticosteroids [<xref ref-type="bibr" rid="CR40">40</xref>], greater health care utilization and a higher prevalence of chronic bronchitis. Multiple risk factors contribute to these adverse outcomes experienced by smokers with asthma, including current or former smoking status, cumulative exposure to cigarette smoke and coexistent social factors such as lower socioeconomic status and environmental exposures such as air pollution [<xref ref-type="bibr" rid="CR40">40</xref>]. Smoking status and smoking duration are both strongly related in a dose-dependent manner to the level of asthma severity [<xref ref-type="bibr" rid="CR41">41</xref>]. The strongest association with more severe asthma was observed in people who smoked more than 20 pack-years, and a strong association between active smoking and severity of asthma [<xref ref-type="bibr" rid="CR14">14</xref>, <xref ref-type="bibr" rid="CR41">41</xref>].</p><p id="Par13">Tobacco smoke also changes the structure of the airway in people with asthma. This results in increased goblet cell numbers associated with sputum production and increased epithelial thickness linked to breathlessness [<xref ref-type="bibr" rid="CR42">42</xref>]. Therefore, in asthma, current smoking status and cumulative exposure to cigarette smoke are correlated with the development of persistent airflow obstruction over time. Some individuals may have clinical features suggestive of both smoking-related asthma and COPD, which is sometimes called asthma-COPD overlap [<xref ref-type="bibr" rid="CR43">43</xref>]. Smoking increases airway inflammation, epithelial and vascular changes and airway remodelling in such patients [<xref ref-type="bibr" rid="CR19">19</xref>, <xref ref-type="bibr" rid="CR44">44</xref>&#8211;<xref ref-type="bibr" rid="CR47">47</xref>]. Patients with features of both asthma and COPD have more respiratory symptoms, more frequent exacerbations, worse quality of life, a more rapid decline in lung function, greater utilization of health care resources and higher mortality compared with patients with either asthma or COPD alone [<xref ref-type="bibr" rid="CR10">10</xref>, <xref ref-type="bibr" rid="CR47">47</xref>].</p></sec></sec><sec id="Sec8"><title>Electronic cigarettes (e-cigarettes or vaping) and asthma</title><p id="Par14">E-cigarette use has increased in recent years, especially among adolescents and young adults [<xref ref-type="bibr" rid="CR48">48</xref>, <xref ref-type="bibr" rid="CR49">49</xref>]. E-cigarette aerosols can contain carcinogens, such as formaldehyde, as well as elevated levels of fine and ultrafine particles that deliver harmful substances deep into the airways, making the lungs susceptible to injury [<xref ref-type="bibr" rid="CR50">50</xref>] and increasing the likelihood of adverse respiratory effects in users of electronic nicotine-delivery devices [<xref ref-type="bibr" rid="CR25">25</xref>, <xref ref-type="bibr" rid="CR28">28</xref>]. Several cross-sectional and longitudinal studies have reported respiratory symptoms, such as chronic cough, wheezing, asthma and shortness of breath, among adolescent and young adult e-cigarette users [<xref ref-type="bibr" rid="CR51">51</xref>, <xref ref-type="bibr" rid="CR52">52</xref>]. Research shows that e-cigarette use was linked to an increased prevalence of asthma symptoms and exacerbated asthma [<xref ref-type="bibr" rid="CR53">53</xref>], independently of conventional cigarette use and other covariates such as age and gender [<xref ref-type="bibr" rid="CR54">54</xref>], and recent prospective studies in the United States of America (USA) have shown connections between e-cigarette use and respiratory symptoms [<xref ref-type="bibr" rid="CR55">55</xref>, <xref ref-type="bibr" rid="CR56">56</xref>], even when accounting for conventional tobacco use. Notably, dual users of conventional cigarettes and e-cigarettes showed the highest increase in prevalence of asthma symptoms [<xref ref-type="bibr" rid="CR57">57</xref>&#8211;<xref ref-type="bibr" rid="CR59">59</xref>], further increasing the burden of asthma control among vulnerable adolescents.</p></sec><sec id="Sec9"><title>Smoking and corticosteroid sensitivity</title><p id="Par15">According to the Global Initiative for Asthma recommendations [<xref ref-type="bibr" rid="CR10">10</xref>], inhaled corticosteroid (ICS) medications are a highly effective treatment for asthma, reducing the risk and severity of exacerbations and asthma-related mortality. However, there is a relative corticosteroid insensitivity to ICS treatment in current smokers with asthma [<xref ref-type="bibr" rid="CR40">40</xref>]. Research indicates that smokers with asthma have an impaired cutaneous vasoconstrictor response to topical corticosteroids compared with never-smokers with asthma. This suggests that the insensitivity to corticosteroids in smokers with asthma affects tissue sites and may be due to the increase in neutrophilic airway inflammation due to smoking [<xref ref-type="bibr" rid="CR40">40</xref>].</p><p id="Par16">Evidence from randomized controlled trials is limited, as these mostly exclude current smokers with asthma [<xref ref-type="bibr" rid="CR40">40</xref>]. However, people with asthma who smoke show less improvement in respiratory symptoms, lung function and exacerbation rates with ICS compared with those who do not smoke [<xref ref-type="bibr" rid="CR40">40</xref>, <xref ref-type="bibr" rid="CR60">60</xref>&#8211;<xref ref-type="bibr" rid="CR62">62</xref>]. This may be partially improved by using higher doses of ICS [<xref ref-type="bibr" rid="CR63">63</xref>]; however, high dose usages will put these people at risk of developing long-term adverse effects from ICS treatment [<xref ref-type="bibr" rid="CR64">64</xref>, <xref ref-type="bibr" rid="CR65">65</xref>].</p></sec><sec id="Sec10"><title>Impact of smoking cessation on asthma</title><p id="Par17">It is essential that all people with asthma who smoke receive personalized advice and support to quit, emphasizing the benefits in the short- and longer term. In addition to the overarching health benefits associated with smoking cessation, quitting may offer specific asthma-related advantages. Smoking cessation is linked to reduced asthma symptoms [<xref ref-type="bibr" rid="CR66">66</xref>&#8211;<xref ref-type="bibr" rid="CR68">68</xref>], better asthma-related quality of life [<xref ref-type="bibr" rid="CR67">67</xref>], improved lung function [<xref ref-type="bibr" rid="CR66">66</xref>] and reduced airway hyper-responsiveness [<xref ref-type="bibr" rid="CR68">68</xref>]. Additionally, former smokers with asthma often exhibit better symptom control compared to current smokers [<xref ref-type="bibr" rid="CR69">69</xref>]. Since children with asthma are particularly vulnerable to second-hand and third-hand smoke, it is imperative to offer smoking cessation treatment to parents and other household members who smoke [<xref ref-type="bibr" rid="CR10">10</xref>, <xref ref-type="bibr" rid="CR70">70</xref>]. Smoking cessation can improve symptoms and lung function, but the low rates of smoking cessation highlight the need for improved strategies for managing these patients.</p></sec><sec id="Sec11"><title>Population-level interventions to address tobacco use</title><p id="Par18">Population-level interventions to address the im- pact of tobacco on asthma-related morbidity and mortality are essential. World Health Organization (WHO) offers well established tools for implementing tobacco control measures [<xref ref-type="bibr" rid="CR25">25</xref>]. In 2008, WHO introduced the MPOWER package to support countries in implementing the demand reduction measures of the WHO Framework Convention on Tobacco Control (WHO FCTC) [<xref ref-type="bibr" rid="CR71">71</xref>]. Progress is regularly reported through a biennial global tobacco epidemic report [<xref ref-type="bibr" rid="CR25">25</xref>, <xref ref-type="bibr" rid="CR72">72</xref>]. MPOWER contains six tobacco control demand reduction measures aligned with the WHO FCTC.</p><p id="Par19">The WHO package of essential noncommunicable (PEN) disease interventions for primary health care includes a module focused on the management of asthma. PEN emphasizes the importance of informing individuals with asthma about the risks associated with smoking, exposure to indoor and outdoor allergens and the need to stop smoking [<xref ref-type="bibr" rid="CR73">73</xref>]. WHO recommends the following population-level and pharmacological interventions to ensure access to comprehensive cessation support (Table&#160;<xref rid="Tab2" ref-type="table">2</xref>) [<xref ref-type="bibr" rid="CR25">25</xref>].</p><p id="Par20">
<table-wrap id="Tab2" position="float" orientation="portrait"><label>Table 2</label><caption><p>WHO recommended cessation support</p></caption><table frame="hsides" rules="groups"><tbody><tr><td align="left" colspan="1" rowspan="1">Brief advice</td><td align="left" colspan="1" rowspan="1">this is usually a few minutes of advice on how to stop using tobacco, given to all tobacco users during a routine consultation or interaction with any health professional</td></tr><tr><td align="left" colspan="1" rowspan="1">Toll-free quit lines</td><td align="left" colspan="1" rowspan="1">a telephone counselling service that provides proactive and reactive telephone counselling</td></tr><tr><td align="left" colspan="1" rowspan="1">Pharmacological interventions</td><td align="left" colspan="1" rowspan="1">nicotine replacement therapy, bupropion, cytisine, cytisinicline or varenicline should be provided for all tobacco users who want to quit, according to the relevant guidelines</td></tr><tr><td align="left" colspan="1" rowspan="1">mCessation and chatbots</td><td align="left" colspan="1" rowspan="1">a two-way messaging system based on the mCessation content library [<xref ref-type="bibr" rid="CR89">89</xref>] guides tobacco users through a six-month text message quit support programme. WHO has also developed chatbots in partnership with WhatsApp, WeChat and Viber to give tobacco users the best advice on how to quit tobacco</td></tr><tr><td align="left" colspan="1" rowspan="1">WHO Quit Tobacco app</td><td align="left" colspan="1" rowspan="1">the app targets all forms of tobacco, including smokeless and other newer products. It helps users identify triggers, set tar- gets, manage craving and stay focused on quitting tobacco</td></tr></tbody></table></table-wrap>
</p></sec><sec id="Sec12"><title>Emerging concerns and future directions</title><p id="Par21">Exposure to tobacco smoke (either directly or second-hand) damages the lungs, increasing the risk of chronic respiratory diseases, such as asthma and COPD, and it is particularly harmful during lung growth and development (in utero and in childhood and adolescence). It is crucial to stop smoking as early as possible. Some countries are considering increasing the legal smoking age in the so-called Tobacco End Game strategy, as in New Zealand, where the Parliament passed the world&#8217;s first legislation to raise the smoking age to stop those born after January 2009 from buying smoked tobacco products legally, to help eliminate smoking among the next generation [<xref ref-type="bibr" rid="CR74">74</xref>]. Tobacco policy simulation models have shown that the Smokefree Action Plan delivers significant economic benefits, positively impacts public finances, and reduces tobacco-related mortality [<xref ref-type="bibr" rid="CR75">75</xref>]. Despite more than 60% of the public opposing the move, the sixth National-led coalition government repealed the law [<xref ref-type="bibr" rid="CR76">76</xref>]. Health professionals have expressed concerns that this decision could increase healthcare costs and tobacco-related deaths [<xref ref-type="bibr" rid="CR76">76</xref>]. Meanwhile, the &#8220;smokefree generation&#8221; policy continues to gain momentum in other countries. In the UK, the government has introduced a comprehensive tobacco control strategy aimed at establishing a smokefree generation, including a proposed ban on the sale of tobacco products to anyone born after 2008 [<xref ref-type="bibr" rid="CR77">77</xref>]. The policy also targets youth vaping by reducing its appeal and tightening restrictions on e-cigarette availability [<xref ref-type="bibr" rid="CR78">78</xref>]. Similarly, in the Netherland, the government has enforced strong tobacco control measures, such as banning smoking on school premises, prohibiting tobacco sales in supermarkets [<xref ref-type="bibr" rid="CR79">79</xref>]. Tobacco control remains a long-term public health commitment.</p><p id="Par22">The key management strategies to reduce exposure to smoke among people with asthma include advice on smoking cessation and support in quitting, addressing risk factors through legislative measures, such as cigarette smoke (direct and second-hand), and targeting treatable elements related to behavioural and extrapulmonary comorbidities, such as physical inactivity, obesity, anxiety and depression [<xref ref-type="bibr" rid="CR80">80</xref>]. Significant action is needed by individuals, health care professionals, communities, civil society, researchers and policy-makers to achieve a world free of tobacco.</p><p id="Par23">The tobacco use rate is expected to decrease in all WHO regions between 2010 and 2025 [<xref ref-type="bibr" rid="CR25">25</xref>, <xref ref-type="bibr" rid="CR81">81</xref>]. However, at least 38&#160;million adolescents aged 13&#8211;15 years are reported to use any form of tobacco globally [<xref ref-type="bibr" rid="CR81">81</xref>]. Projections indicate that, globally, the number of smokers will remain constant at 1.1&#160;billion up to 2025, owing to increased population size and new smokers. Studies consistently show that young people who use e-cigarettes are almost three times more likely to use conventional cigarettes later in life [<xref ref-type="bibr" rid="CR82">82</xref>]. Urgent measures are necessary to prevent uptake of e-cigarettes and counter nicotine addiction, alongside a comprehensive approach to tobacco control and in the light of national circumstances [<xref ref-type="bibr" rid="CR82">82</xref>]. These actions aim to prevent the long-term effects of developing chronic respiratory disease.</p><p id="Par24">As an integral part of the wider indoor pollution policies and plans, laws that make indoor public places completely smoke-free are an important policy to help with asthma control and management of treatment outcomes [<xref ref-type="bibr" rid="CR25">25</xref>, <xref ref-type="bibr" rid="CR83">83</xref>]. There is evidence that, whenever smoke-free laws are implemented, they are followed by an almost immediate drop in second-hand smoke pollution levels and by marked improvements in respiratory health [<xref ref-type="bibr" rid="CR84">84</xref>]. One of the earliest studies on second-hand smoke, conducted on bar workers in Scotland, reported a 26% decrease in respiratory symptoms, and asthmatic bar workers had reduced airway inflammation within three months of comprehensive smoke-free legislation being enacted [<xref ref-type="bibr" rid="CR25">25</xref>, <xref ref-type="bibr" rid="CR85">85</xref>]. Today, there is robust evidence that comprehensive smoke-free laws result in reduced hospital admissions for acute coronary syndrome [<xref ref-type="bibr" rid="CR86">86</xref>] and reduced mortality from smoking-related illnesses, and improve cardiovascular health outcomes [<xref ref-type="bibr" rid="CR87">87</xref>]. Alongside smoke-free policies, banning any form of tobacco advertising, promotion or sponsorship and adopting consistent regulatory measures for new and emerging tobacco and nicotine products to protect the youth population are crucial.</p><p id="Par25">It is imperative for health care providers and policy-makers to guarantee that all individuals, including vulnerable populations, are safeguarded by legislation, and provided with the necessary knowledge and resources to quit tobacco and nicotine use and stay tobacco free. Table&#160;<xref rid="Tab3" ref-type="table">3</xref> summarizes the key messages from the WHO Tobacco Knowledge Summary [<xref ref-type="bibr" rid="CR88">88</xref>] shared with the wider population.</p><p id="Par26">
<table-wrap id="Tab3" position="float" orientation="portrait"><label>Table 3</label><caption><p>WHO TKS key message</p></caption><table frame="hsides" rules="groups"><tbody><tr><td align="left" colspan="1" rowspan="1">1. Babies born to mothers who smoke have smaller lungs and an increased risk of developing asthma during childhood. Pregnant women should receive targeted support to quit tobacco use.</td></tr><tr><td align="left" colspan="1" rowspan="1">2. Children exposed to second-hand tobacco smoke have an increased risk of developing asthma.</td></tr><tr><td align="left" colspan="1" rowspan="1">3. Smoking during adolescence and adulthood increases the risk of developing asthma and exacerbates the condition, as well as causing other lung diseases such as chronic obstructive pulmonary disease (COPD) and lung cancer.</td></tr><tr><td align="left" colspan="1" rowspan="1">4. For people living with asthma, smoking worsens symptoms and can make treatment with medications less effective. All smokers with asthma should be supported to quit smoking.</td></tr><tr><td align="left" colspan="1" rowspan="1">5. E-cigarettes, heated tobacco products and other nicotine-delivery devices likely also carry risks. Governments should implement effective tobacco control measures to protect all individuals, including those who are vulnerable.</td></tr><tr><td align="left" colspan="1" rowspan="1">6. The tobacco and nicotine industries&#8217; aggressive tactics in the marketing of their products specifically target children, adolescents and young adults. Protecting youth from these harmful tactics is a top priority.</td></tr></tbody></table></table-wrap>
</p></sec></body><back><fn-group><fn><p><bold>Publisher&#8217;s note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group><ack><title>Acknowledgements</title><p>Not applicable.</p></ack><notes notes-type="author-contribution"><title>Author contributions</title><p>WL, SR, RA, SSS conceived, designed the structure of the article, revised, and edited. WL wrote the first draft, made figures, and made revisions. KS, EL, WB, JH, JBS, AY and DCLL reviewed and edited the manuscript.</p></notes><notes notes-type="funding-information"><title>Funding</title><p>Clifford Craig Foundation Launceston General Hospital.</p></notes><notes notes-type="data-availability"><title>Data availability</title><p>No datasets were generated or analysed during the current study.</p></notes><notes><title>Declarations</title><notes id="FPar2"><title>Ethics declarations</title><p id="Par27">Not applicable.</p></notes><notes id="FPar3"><title>Consent to publish</title><p id="Par28">Not applicable.</p></notes><notes id="FPar4"><title>Disclaimer</title><p id="Par29">The authors alone are responsible for the views expressed in this article and they do not necessarily represent the views, decisions, or policies of the institutions with which they are affiliated.</p></notes><notes id="FPar5" notes-type="COI-statement"><title>Conflict of interest</title><p id="Par30">Declaration of competing interests: Dr Sohal reports honorarium for lectures from Chiesi, travel support from Chiesi, AstraZeneca, Boehringer Ingelheim and GSK, and research grants from Boehringer Ingelheim and Lung Therapeutics, outside the submitted work; and has served on the small airway advisory board for Chiesi Australia for which an honorarium has been received. Dr Sohal has served as Chair for the Chiesi Advisory Board for Centre of Excellence in Oscillometry, for which an honorarium was received.</p></notes></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><mixed-citation publication-type="other">Asthma [fact sheet]. World Health Organization. 2023 [Available from: <ext-link ext-link-type="uri" xlink:href="https://www.who.int/news-room/fact-sheets/detail/asthma">https://www.who.int/news-room/fact-sheets/detail/asthma</ext-link></mixed-citation></ref><ref id="CR2"><label>2.</label><mixed-citation publication-type="other">What is asthma? [website]. National Asthma Council Australia. 2023 [Available from: <ext-link ext-link-type="uri" xlink:href="https://www.nationalasthma.org.au/understanding-asthma/what-is-asthma">https://www.nationalasthma.org.au/understanding-asthma/what-is-asthma</ext-link></mixed-citation></ref><ref id="CR3"><label>3.</label><mixed-citation publication-type="other">What is Asthma? [fact sheet]. National Heart, Lung, and Blood Institute. 2024 [Available from: <ext-link ext-link-type="uri" xlink:href="https://www.nhlbi.nih.gov/BreatheBetter">https://www.nhlbi.nih.gov/BreatheBetter</ext-link></mixed-citation></ref><ref id="CR4"><label>4.</label><citation-alternatives><element-citation id="ec-CR4" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Luis</surname><given-names>G-M</given-names></name><name name-style="western"><surname>Asher</surname><given-names>MI</given-names></name><name name-style="western"><surname>Neil</surname><given-names>P</given-names></name><name name-style="western"><surname>Eamon</surname><given-names>E</given-names></name><name name-style="western"><surname>Karen</surname><given-names>B</given-names></name><name name-style="western"><surname>Chen-Yuan</surname><given-names>C</given-names></name><etal/></person-group><article-title>The burden of asthma, hay fever and eczema in children in 25 countries: GAN phase I study</article-title><source>Eur Respir J</source><year>2022</year><volume>60</volume><issue>3</issue><fpage>2102866</fpage><pub-id pub-id-type="pmid">35144987</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1183/13993003.02866-2021</pub-id><pub-id pub-id-type="pmcid">PMC9474895</pub-id></element-citation><mixed-citation id="mc-CR4" publication-type="journal">Luis G-M, Asher MI, Neil P, Eamon E, Karen B, Chen-Yuan C, et al. The burden of asthma, hay fever and eczema in children in 25 countries: GAN phase I study. Eur Respir J. 2022;60(3):2102866.<pub-id pub-id-type="pmid">35144987</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1183/13993003.02866-2021</pub-id><pub-id pub-id-type="pmcid">PMC9474895</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR5"><label>5.</label><citation-alternatives><element-citation id="ec-CR5" publication-type="journal"><person-group person-group-type="author"><collab>GBD 2019 Diseases and Injuries Collaborators</collab></person-group><article-title>Global burden of 369 diseases and injuries in 204 countries and territories, 1990&#8211;2019: a systematic analysis for the global burden of disease study 2019</article-title><source>Lancet</source><year>2020</year><volume>396</volume><issue>10258</issue><fpage>1204</fpage><lpage>22</lpage><pub-id pub-id-type="pmid">33069326</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/S0140-6736(20)30925-9</pub-id><pub-id pub-id-type="pmcid">PMC7567026</pub-id></element-citation><mixed-citation id="mc-CR5" publication-type="journal">GBD 2019 Diseases and Injuries Collaborators. Global burden of 369 diseases and injuries in 204 countries and territories, 1990&#8211;2019: a systematic analysis for the global burden of disease study 2019. Lancet. 2020;396(10258):1204&#8211;22.<pub-id pub-id-type="pmid">33069326</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/S0140-6736(20)30925-9</pub-id><pub-id pub-id-type="pmcid">PMC7567026</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR6"><label>6.</label><citation-alternatives><element-citation id="ec-CR6" publication-type="journal"><person-group person-group-type="author"><collab>GBD Chronic Respiratory Disease Collaborators</collab></person-group><article-title>Prevalence and attributable health burden of chronic respiratory diseases, 1990&#8211;2017: a systematic analysis for the global burden of disease study 2017</article-title><source>Lancet Respir Med</source><year>2020</year><volume>8</volume><issue>6</issue><fpage>585</fpage><lpage>96</lpage><pub-id pub-id-type="pmid">32526187</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/S2213-2600(20)30105-3</pub-id><pub-id pub-id-type="pmcid">PMC7284317</pub-id></element-citation><mixed-citation id="mc-CR6" publication-type="journal">GBD Chronic Respiratory Disease Collaborators. Prevalence and attributable health burden of chronic respiratory diseases, 1990&#8211;2017: a systematic analysis for the global burden of disease study 2017. Lancet Respir Med. 2020;8(6):585&#8211;96.<pub-id pub-id-type="pmid">32526187</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/S2213-2600(20)30105-3</pub-id><pub-id pub-id-type="pmcid">PMC7284317</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR7"><label>7.</label><citation-alternatives><element-citation id="ec-CR7" publication-type="book"><person-group person-group-type="author"><collab>Chronic respiratory diseases and health equity</collab></person-group><source>By 2050: a spotlight on chronic obstructive pulmonary disease and asthma in the WHO European region</source><year>2025</year><publisher-loc>Copenhagen</publisher-loc><publisher-name>WHO Regional Office for Europe</publisher-name></element-citation><mixed-citation id="mc-CR7" publication-type="book">Chronic respiratory diseases and health equity. By 2050: a spotlight on chronic obstructive pulmonary disease and asthma in the WHO European region. Copenhagen: WHO Regional Office for Europe; 2025. Contract No.: WHO/EURO:2025-12340-52112-79990.</mixed-citation></citation-alternatives></ref><ref id="CR8"><label>8.</label><mixed-citation publication-type="other">The Global Asthma Report. 2022. Int J Tuberc Lung Dis. 2022;26:1-104.<pub-id pub-id-type="doi" assigning-authority="pmc">10.5588/ijtld.22.1010</pub-id><pub-id pub-id-type="pmid">36303302</pub-id></mixed-citation></ref><ref id="CR9"><label>9.</label><citation-alternatives><element-citation id="ec-CR9" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nunes</surname><given-names>C</given-names></name><name name-style="western"><surname>Pereira</surname><given-names>AM</given-names></name><name name-style="western"><surname>Morais-Almeida</surname><given-names>M</given-names></name></person-group><article-title>Asthma costs and social impact</article-title><source>Asthma Res Pract</source><year>2017</year><volume>3</volume><issue>1</issue><fpage>1</fpage><pub-id pub-id-type="pmid">28078100</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s40733-016-0029-3</pub-id><pub-id pub-id-type="pmcid">PMC5219738</pub-id></element-citation><mixed-citation id="mc-CR9" publication-type="journal">Nunes C, Pereira AM, Morais-Almeida M. Asthma costs and social impact. Asthma Res Pract. 2017;3(1):1.<pub-id pub-id-type="pmid">28078100</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s40733-016-0029-3</pub-id><pub-id pub-id-type="pmcid">PMC5219738</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR10"><label>10.</label><mixed-citation publication-type="other">Global Strategy for Asthma Management and Prevention. 2023: Fontana (WI): Global Initiative for Asthma; 2023 [Available from: <ext-link ext-link-type="uri" xlink:href="https://ginasthma.org/2023-gina-main-report/">https://ginasthma.org/2023-gina-main-report/</ext-link></mixed-citation></ref><ref id="CR11"><label>11.</label><mixed-citation publication-type="other">Enilari O, Sinha S. The global impact of asthma in adult populations. Ann Glob Health. 2019;85(1).<pub-id pub-id-type="doi" assigning-authority="pmc">10.5334/aogh.2412</pub-id><pub-id pub-id-type="pmcid">PMC7052341</pub-id><pub-id pub-id-type="pmid">30741503</pub-id></mixed-citation></ref><ref id="CR12"><label>12.</label><mixed-citation publication-type="other">Mortimer K, Reddel HK, Pitrez PM, Bateman ED. Asthma management in low and middle income countries: case for change. Eur Respir J. 2022;60(3).<pub-id pub-id-type="doi" assigning-authority="pmc">10.1183/13993003.03179-2021</pub-id><pub-id pub-id-type="pmcid">PMC9474897</pub-id><pub-id pub-id-type="pmid">35210321</pub-id></mixed-citation></ref><ref id="CR13"><label>13.</label><citation-alternatives><element-citation id="ec-CR13" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Samet</surname><given-names>JM</given-names></name></person-group><article-title>Tobacco smoking: the leading cause of preventable disease worldwide</article-title><source>Thorac Surg Clin</source><year>2013</year><volume>23</volume><issue>2</issue><fpage>103</fpage><lpage>12</lpage><pub-id pub-id-type="pmid">23566962</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.thorsurg.2013.01.009</pub-id></element-citation><mixed-citation id="mc-CR13" publication-type="journal">Samet JM. Tobacco smoking: the leading cause of preventable disease worldwide. Thorac Surg Clin. 2013;23(2):103&#8211;12.<pub-id pub-id-type="pmid">23566962</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.thorsurg.2013.01.009</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR14"><label>14.</label><citation-alternatives><element-citation id="ec-CR14" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Polosa</surname><given-names>R</given-names></name><name name-style="western"><surname>Thomson</surname><given-names>NC</given-names></name></person-group><article-title>Smoking and asthma: dangerous liaisons</article-title><source>Eur Respir J</source><year>2013</year><volume>41</volume><issue>3</issue><fpage>716</fpage><lpage>26</lpage><pub-id pub-id-type="pmid">22903959</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1183/09031936.00073312</pub-id></element-citation><mixed-citation id="mc-CR14" publication-type="journal">Polosa R, Thomson NC. Smoking and asthma: dangerous liaisons. Eur Respir J. 2013;41(3):716&#8211;26.<pub-id pub-id-type="pmid">22903959</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1183/09031936.00073312</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR15"><label>15.</label><citation-alternatives><element-citation id="ec-CR15" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Piipari</surname><given-names>R</given-names></name><name name-style="western"><surname>JJJ</surname><given-names>K</given-names></name><name name-style="western"><surname>Jaakkola</surname><given-names>N</given-names></name><name name-style="western"><surname>Jaakkola</surname><given-names>MS</given-names></name></person-group><article-title>Smoking and asthma in adults</article-title><source>Eur Respir J</source><year>2004</year><volume>24</volume><issue>5</issue><fpage>734</fpage><pub-id pub-id-type="pmid">15516665</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1183/09031936.04.00116903</pub-id></element-citation><mixed-citation id="mc-CR15" publication-type="journal">Piipari R, JJJ K, Jaakkola N, Jaakkola MS. Smoking and asthma in adults. Eur Respir J. 2004;24(5):734.<pub-id pub-id-type="pmid">15516665</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1183/09031936.04.00116903</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR16"><label>16.</label><citation-alternatives><element-citation id="ec-CR16" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Plaschke</surname><given-names>PP</given-names></name><name name-style="western"><surname>Janson</surname><given-names>C</given-names></name><name name-style="western"><surname>Norrman</surname><given-names>E</given-names></name><name name-style="western"><surname>Bj&#246;rnsson</surname><given-names>E</given-names></name><name name-style="western"><surname>Ellbj&#228;r</surname><given-names>S</given-names></name><name name-style="western"><surname>J&#228;rvholm</surname><given-names>B</given-names></name></person-group><article-title>Onset and remission of allergic rhinitis and asthma and the relationship with atopic sensitization and smoking</article-title><source>Am J Respir Crit Care Med</source><year>2000</year><volume>162</volume><issue>3 Pt 1</issue><fpage>920</fpage><lpage>4</lpage><pub-id pub-id-type="pmid">10988106</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1164/ajrccm.162.3.9912030</pub-id></element-citation><mixed-citation id="mc-CR16" publication-type="journal">Plaschke PP, Janson C, Norrman E, Bj&#246;rnsson E, Ellbj&#228;r S, J&#228;rvholm B. Onset and remission of allergic rhinitis and asthma and the relationship with atopic sensitization and smoking. Am J Respir Crit Care Med. 2000;162(3 Pt 1):920&#8211;4.<pub-id pub-id-type="pmid">10988106</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1164/ajrccm.162.3.9912030</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR17"><label>17.</label><citation-alternatives><element-citation id="ec-CR17" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Annesi-Maesano</surname><given-names>I</given-names></name><name name-style="western"><surname>Oryszczyn</surname><given-names>MP</given-names></name><name name-style="western"><surname>Raherison</surname><given-names>C</given-names></name><name name-style="western"><surname>Kopferschmitt</surname><given-names>C</given-names></name><name name-style="western"><surname>Pauli</surname><given-names>G</given-names></name><name name-style="western"><surname>Taytard</surname><given-names>A</given-names></name><etal/></person-group><article-title>Increased prevalence of asthma and allied diseases among active adolescent tobacco smokers after controlling for passive smoking exposure. A cause for concern?</article-title><source>Clin Exp Allergy</source><year>2004</year><volume>34</volume><issue>7</issue><fpage>1017</fpage><lpage>23</lpage><pub-id pub-id-type="pmid">15248844</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/j.1365-2222.2004.02002.x</pub-id></element-citation><mixed-citation id="mc-CR17" publication-type="journal">Annesi-Maesano I, Oryszczyn MP, Raherison C, Kopferschmitt C, Pauli G, Taytard A, et al. Increased prevalence of asthma and allied diseases among active adolescent tobacco smokers after controlling for passive smoking exposure. A cause for concern? Clin Exp Allergy. 2004;34(7):1017&#8211;23.<pub-id pub-id-type="pmid">15248844</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/j.1365-2222.2004.02002.x</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR18"><label>18.</label><citation-alternatives><element-citation id="ec-CR18" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Arnulf</surname><given-names>L</given-names></name><name name-style="western"><surname>Roar</surname><given-names>J</given-names></name><name name-style="western"><surname>Jostein</surname><given-names>H</given-names></name><name name-style="western"><surname>Gulsvik</surname><given-names>A</given-names></name><name name-style="western"><surname>Bjermer</surname><given-names>L</given-names></name></person-group><article-title>Cigarette smoking gives more respiratory symptoms among women than among men the Nord-Tr&#248;ndelag health study (HUNT)</article-title><source>J Epidemiol Commun Health</source><year>2000</year><volume>54</volume><issue>12</issue><fpage>917</fpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/jech.54.12.917</pub-id><pub-id pub-id-type="pmcid">PMC1731608</pub-id><pub-id pub-id-type="pmid">11076988</pub-id></element-citation><mixed-citation id="mc-CR18" publication-type="journal">Arnulf L, Roar J, Jostein H, Gulsvik A, Bjermer L. Cigarette smoking gives more respiratory symptoms among women than among men the Nord-Tr&#248;ndelag health study (HUNT). J Epidemiol Commun Health. 2000;54(12):917.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/jech.54.12.917</pub-id><pub-id pub-id-type="pmcid">PMC1731608</pub-id><pub-id pub-id-type="pmid">11076988</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR19"><label>19.</label><citation-alternatives><element-citation id="ec-CR19" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dey</surname><given-names>S</given-names></name><name name-style="western"><surname>Lu</surname><given-names>W</given-names></name><name name-style="western"><surname>Haug</surname><given-names>G</given-names></name><name name-style="western"><surname>Chia</surname><given-names>C</given-names></name><name name-style="western"><surname>Larby</surname><given-names>J</given-names></name><name name-style="western"><surname>Weber</surname><given-names>HC</given-names></name><etal/></person-group><article-title>Airway inflammatory changes in the lungs of patients with asthma-COPD overlap (ACO): a bronchoscopy endobronchial biopsy study</article-title><source>Respir Res</source><year>2023</year><volume>24</volume><issue>1</issue><fpage>221</fpage><pub-id pub-id-type="pmid">37700291</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s12931-023-02527-x</pub-id><pub-id pub-id-type="pmcid">PMC10498556</pub-id></element-citation><mixed-citation id="mc-CR19" publication-type="journal">Dey S, Lu W, Haug G, Chia C, Larby J, Weber HC, et al. Airway inflammatory changes in the lungs of patients with asthma-COPD overlap (ACO): a bronchoscopy endobronchial biopsy study. Respir Res. 2023;24(1):221.<pub-id pub-id-type="pmid">37700291</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s12931-023-02527-x</pub-id><pub-id pub-id-type="pmcid">PMC10498556</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR20"><label>20.</label><citation-alternatives><element-citation id="ec-CR20" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Thomson</surname><given-names>NC</given-names></name><name name-style="western"><surname>Spears</surname><given-names>M</given-names></name></person-group><article-title>The role of cigarette smoking on persistent airflow obstruction in asthma</article-title><source>Annals Resp Med</source><year>2011</year><volume>2</volume><issue>1</issue><fpage>47</fpage><lpage>54</lpage></element-citation><mixed-citation id="mc-CR20" publication-type="journal">Thomson NC, Spears M. The role of cigarette smoking on persistent airflow obstruction in asthma. Annals Resp Med. 2011;2(1):47&#8211;54.</mixed-citation></citation-alternatives></ref><ref id="CR21"><label>21.</label><citation-alternatives><element-citation id="ec-CR21" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lid&#243;n-Moyano</surname><given-names>C</given-names></name><name name-style="western"><surname>Fu</surname><given-names>M</given-names></name><name name-style="western"><surname>P&#233;rez-Ortu&#241;o</surname><given-names>R</given-names></name><name name-style="western"><surname>Ballb&#232;</surname><given-names>M</given-names></name><name name-style="western"><surname>Garcia</surname><given-names>E</given-names></name><name name-style="western"><surname>Mart&#237;n-S&#225;nchez</surname><given-names>JC</given-names></name><etal/></person-group><article-title>Third-hand exposure at homes: assessment using salivary cotinine</article-title><source>Environ Res</source><year>2021</year><volume>196</volume><fpage>110393</fpage><pub-id pub-id-type="pmid">33129855</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.envres.2020.110393</pub-id></element-citation><mixed-citation id="mc-CR21" publication-type="journal">Lid&#243;n-Moyano C, Fu M, P&#233;rez-Ortu&#241;o R, Ballb&#232; M, Garcia E, Mart&#237;n-S&#225;nchez JC, et al. Third-hand exposure at homes: assessment using salivary cotinine. Environ Res. 2021;196:110393.<pub-id pub-id-type="pmid">33129855</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.envres.2020.110393</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR22"><label>22.</label><citation-alternatives><element-citation id="ec-CR22" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Stapleton</surname><given-names>M</given-names></name><name name-style="western"><surname>Howard-Thompson</surname><given-names>A</given-names></name><name name-style="western"><surname>George</surname><given-names>C</given-names></name><name name-style="western"><surname>Hoover</surname><given-names>RM</given-names></name><name name-style="western"><surname>Self</surname><given-names>TH</given-names></name></person-group><article-title>Smoking and asthma</article-title><source>J Am Board Fam Med</source><year>2011</year><volume>24</volume><issue>3</issue><fpage>313</fpage><lpage>22</lpage><pub-id pub-id-type="pmid">21551404</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3122/jabfm.2011.03.100180</pub-id></element-citation><mixed-citation id="mc-CR22" publication-type="journal">Stapleton M, Howard-Thompson A, George C, Hoover RM, Self TH. Smoking and asthma. J Am Board Fam Med. 2011;24(3):313&#8211;22.<pub-id pub-id-type="pmid">21551404</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3122/jabfm.2011.03.100180</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR23"><label>23.</label><mixed-citation publication-type="other">Thorpe AE, Donovan C, Kim RY, Vindin HJ, Zakarya R, Miyai H et al. Third-Hand exposure to E-Cigarette vapour induces pulmonary effects in mice. Toxics. 2023;11(9).<pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/toxics11090749</pub-id><pub-id pub-id-type="pmcid">PMC10536515</pub-id><pub-id pub-id-type="pmid">37755759</pub-id></mixed-citation></ref><ref id="CR24"><label>24.</label><mixed-citation publication-type="other">National Center for Chronic Disease Prevention and Health Promotion (US) Office on Smoking and Health. The Health Consequences of Smoking&#8212;50 Years of Progress: a report of the Surgeon General: Atlanta (GA): Centers for Disease Control and Prevention. 2014 [Available from: <ext-link ext-link-type="uri" xlink:href="https://archive.cdc.gov/#/details?url=https://www.cdc.gov/tobacco/sgr/50th-anniversary/index.htm">https://archive.cdc.gov/#/details?url=https://www.cdc.gov/tobacco/sgr/50th-anniversary/index.htm</ext-link><pub-id pub-id-type="pmid">24455788</pub-id></mixed-citation></ref><ref id="CR25"><label>25.</label><mixed-citation publication-type="other">WHO Report on the Global Tobacco Epidemic. 2023: protect people from tobacco smoke: Geneva: World Health Organization; 2023.</mixed-citation></ref><ref id="CR26"><label>26.</label><mixed-citation publication-type="other">Braun M, Klingelh&#246;fer D, Oremek GM, Quarcoo D, Groneberg DA. Influence of Second-Hand smoke and prenatal tobacco smoke exposure on biomarkers, genetics and physiological processes in Children-An overview in research insights of the last few years. Int J Environ Res Public Health. 2020;17(9).<pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/ijerph17093212</pub-id><pub-id pub-id-type="pmcid">PMC7246681</pub-id><pub-id pub-id-type="pmid">32380770</pub-id></mixed-citation></ref><ref id="CR27"><label>27.</label><citation-alternatives><element-citation id="ec-CR27" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Banderali</surname><given-names>G</given-names></name><name name-style="western"><surname>Martelli</surname><given-names>A</given-names></name><name name-style="western"><surname>Landi</surname><given-names>M</given-names></name><name name-style="western"><surname>Moretti</surname><given-names>F</given-names></name><name name-style="western"><surname>Betti</surname><given-names>F</given-names></name><name name-style="western"><surname>Radaelli</surname><given-names>G</given-names></name><etal/></person-group><article-title>Short and long term health effects of parental tobacco smoking during pregnancy and lactation: a descriptive review</article-title><source>J Transl Med</source><year>2015</year><volume>13</volume><fpage>327</fpage><pub-id pub-id-type="pmid">26472248</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s12967-015-0690-y</pub-id><pub-id pub-id-type="pmcid">PMC4608184</pub-id></element-citation><mixed-citation id="mc-CR27" publication-type="journal">Banderali G, Martelli A, Landi M, Moretti F, Betti F, Radaelli G, et al. Short and long term health effects of parental tobacco smoking during pregnancy and lactation: a descriptive review. J Transl Med. 2015;13:327.<pub-id pub-id-type="pmid">26472248</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s12967-015-0690-y</pub-id><pub-id pub-id-type="pmcid">PMC4608184</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR28"><label>28.</label><citation-alternatives><element-citation id="ec-CR28" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Blatt</surname><given-names>K</given-names></name><name name-style="western"><surname>Moore</surname><given-names>E</given-names></name><name name-style="western"><surname>Chen</surname><given-names>A</given-names></name><name name-style="western"><surname>Van Hook</surname><given-names>J</given-names></name><name name-style="western"><surname>DeFranco</surname><given-names>EA</given-names></name></person-group><article-title>Association of reported trimester-specific smoking cessation with fetal growth restriction</article-title><source>Obstet Gynecol</source><year>2015</year><volume>125</volume><issue>6</issue><fpage>1452</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">26000517</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/AOG.0000000000000679</pub-id><pub-id pub-id-type="pmcid">PMC5215872</pub-id></element-citation><mixed-citation id="mc-CR28" publication-type="journal">Blatt K, Moore E, Chen A, Van Hook J, DeFranco EA. Association of reported trimester-specific smoking cessation with fetal growth restriction. Obstet Gynecol. 2015;125(6):1452&#8211;9.<pub-id pub-id-type="pmid">26000517</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/AOG.0000000000000679</pub-id><pub-id pub-id-type="pmcid">PMC5215872</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR29"><label>29.</label><citation-alternatives><element-citation id="ec-CR29" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ko</surname><given-names>TJ</given-names></name><name name-style="western"><surname>Tsai</surname><given-names>LY</given-names></name><name name-style="western"><surname>Chu</surname><given-names>LC</given-names></name><name name-style="western"><surname>Yeh</surname><given-names>SJ</given-names></name><name name-style="western"><surname>Leung</surname><given-names>C</given-names></name><name name-style="western"><surname>Chen</surname><given-names>CY</given-names></name><etal/></person-group><article-title>Parental smoking during pregnancy and its association with low birth weight, small for gestational age, and preterm birth offspring: a birth cohort study</article-title><source>Pediatr Neonatol</source><year>2014</year><volume>55</volume><issue>1</issue><fpage>20</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">23850094</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.pedneo.2013.05.005</pub-id></element-citation><mixed-citation id="mc-CR29" publication-type="journal">Ko TJ, Tsai LY, Chu LC, Yeh SJ, Leung C, Chen CY, et al. Parental smoking during pregnancy and its association with low birth weight, small for gestational age, and preterm birth offspring: a birth cohort study. Pediatr Neonatol. 2014;55(1):20&#8211;7.<pub-id pub-id-type="pmid">23850094</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.pedneo.2013.05.005</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR30"><label>30.</label><citation-alternatives><element-citation id="ec-CR30" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lanner&#246;</surname><given-names>E</given-names></name><name name-style="western"><surname>Wickman</surname><given-names>M</given-names></name><name name-style="western"><surname>Pershagen</surname><given-names>G</given-names></name><name name-style="western"><surname>Nordvall</surname><given-names>L</given-names></name></person-group><article-title>Maternal smoking during pregnancy increases the risk of recurrent wheezing during the first years of life (BAMSE)</article-title><source>Respir Res</source><year>2006</year><volume>7</volume><issue>1</issue><fpage>3</fpage><pub-id pub-id-type="pmid">16396689</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/1465-9921-7-3</pub-id><pub-id pub-id-type="pmcid">PMC1360665</pub-id></element-citation><mixed-citation id="mc-CR30" publication-type="journal">Lanner&#246; E, Wickman M, Pershagen G, Nordvall L. Maternal smoking during pregnancy increases the risk of recurrent wheezing during the first years of life (BAMSE). Respir Res. 2006;7(1):3.<pub-id pub-id-type="pmid">16396689</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/1465-9921-7-3</pub-id><pub-id pub-id-type="pmcid">PMC1360665</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR31"><label>31.</label><citation-alternatives><element-citation id="ec-CR31" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cheraghi</surname><given-names>M</given-names></name><name name-style="western"><surname>Salvi</surname><given-names>S</given-names></name></person-group><article-title>Environmental tobacco smoke (ETS) and respiratory health in children</article-title><source>Eur J Pediatr</source><year>2009</year><volume>168</volume><issue>8</issue><fpage>897</fpage><lpage>905</lpage><pub-id pub-id-type="pmid">19301035</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s00431-009-0967-3</pub-id></element-citation><mixed-citation id="mc-CR31" publication-type="journal">Cheraghi M, Salvi S. Environmental tobacco smoke (ETS) and respiratory health in children. Eur J Pediatr. 2009;168(8):897&#8211;905.<pub-id pub-id-type="pmid">19301035</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s00431-009-0967-3</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR32"><label>32.</label><citation-alternatives><element-citation id="ec-CR32" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Burke</surname><given-names>H</given-names></name><name name-style="western"><surname>Leonardi-Bee</surname><given-names>J</given-names></name><name name-style="western"><surname>Hashim</surname><given-names>A</given-names></name><name name-style="western"><surname>Pine-Abata</surname><given-names>H</given-names></name><name name-style="western"><surname>Chen</surname><given-names>Y</given-names></name><name name-style="western"><surname>Cook</surname><given-names>DG</given-names></name><etal/></person-group><article-title>Prenatal and passive smoke exposure and incidence of asthma and wheeze: systematic review and meta-analysis</article-title><source>Pediatrics</source><year>2012</year><volume>129</volume><issue>4</issue><fpage>735</fpage><lpage>44</lpage><pub-id pub-id-type="pmid">22430451</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1542/peds.2011-2196</pub-id></element-citation><mixed-citation id="mc-CR32" publication-type="journal">Burke H, Leonardi-Bee J, Hashim A, Pine-Abata H, Chen Y, Cook DG, et al. Prenatal and passive smoke exposure and incidence of asthma and wheeze: systematic review and meta-analysis. Pediatrics. 2012;129(4):735&#8211;44.<pub-id pub-id-type="pmid">22430451</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1542/peds.2011-2196</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR33"><label>33.</label><citation-alternatives><element-citation id="ec-CR33" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Doherty</surname><given-names>SP</given-names></name><name name-style="western"><surname>Grabowski</surname><given-names>J</given-names></name><name name-style="western"><surname>Hoffman</surname><given-names>C</given-names></name><name name-style="western"><surname>Ng</surname><given-names>SP</given-names></name><name name-style="western"><surname>Zelikoff</surname><given-names>JT</given-names></name></person-group><article-title>Early life insult from cigarette smoke May be predictive of chronic diseases later in life</article-title><source>Biomarkers</source><year>2009</year><volume>14</volume><issue>Suppl 1</issue><fpage>97</fpage><lpage>101</lpage><pub-id pub-id-type="pmid">19604068</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1080/13547500902965898</pub-id></element-citation><mixed-citation id="mc-CR33" publication-type="journal">Doherty SP, Grabowski J, Hoffman C, Ng SP, Zelikoff JT. Early life insult from cigarette smoke May be predictive of chronic diseases later in life. Biomarkers. 2009;14(Suppl 1):97&#8211;101.<pub-id pub-id-type="pmid">19604068</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1080/13547500902965898</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR34"><label>34.</label><mixed-citation publication-type="other">Bellou V, Gogali A, Kostikas K. Asthma and tobacco smoking. J Pers Med. 2022;12(8).<pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/jpm12081231</pub-id><pub-id pub-id-type="pmcid">PMC9409665</pub-id><pub-id pub-id-type="pmid">36013180</pub-id></mixed-citation></ref><ref id="CR35"><label>35.</label><citation-alternatives><element-citation id="ec-CR35" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gilliland</surname><given-names>FD</given-names></name><name name-style="western"><surname>Islam</surname><given-names>T</given-names></name><name name-style="western"><surname>Berhane</surname><given-names>K</given-names></name><name name-style="western"><surname>Gauderman</surname><given-names>WJ</given-names></name><name name-style="western"><surname>McConnell</surname><given-names>R</given-names></name><name name-style="western"><surname>Avol</surname><given-names>E</given-names></name><etal/></person-group><article-title>Regular smoking and asthma incidence in adolescents</article-title><source>Am J Respir Crit Care Med</source><year>2006</year><volume>174</volume><issue>10</issue><fpage>1094</fpage><lpage>100</lpage><pub-id pub-id-type="pmid">16973983</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1164/rccm.200605-722OC</pub-id><pub-id pub-id-type="pmcid">PMC2648110</pub-id></element-citation><mixed-citation id="mc-CR35" publication-type="journal">Gilliland FD, Islam T, Berhane K, Gauderman WJ, McConnell R, Avol E, et al. Regular smoking and asthma incidence in adolescents. Am J Respir Crit Care Med. 2006;174(10):1094&#8211;100.<pub-id pub-id-type="pmid">16973983</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1164/rccm.200605-722OC</pub-id><pub-id pub-id-type="pmcid">PMC2648110</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR36"><label>36.</label><citation-alternatives><element-citation id="ec-CR36" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Haahtela</surname><given-names>T</given-names></name><name name-style="western"><surname>Tuomisto</surname><given-names>LE</given-names></name><name name-style="western"><surname>Pietinalho</surname><given-names>A</given-names></name><name name-style="western"><surname>Klaukka</surname><given-names>T</given-names></name><name name-style="western"><surname>Erhola</surname><given-names>M</given-names></name><name name-style="western"><surname>Kaila</surname><given-names>M</given-names></name><etal/></person-group><article-title>A 10 year asthma programme in finland: major change for the better</article-title><source>Thorax</source><year>2006</year><volume>61</volume><issue>8</issue><fpage>663</fpage><pub-id pub-id-type="pmid">16877690</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/thx.2005.055699</pub-id><pub-id pub-id-type="pmcid">PMC2104683</pub-id></element-citation><mixed-citation id="mc-CR36" publication-type="journal">Haahtela T, Tuomisto LE, Pietinalho A, Klaukka T, Erhola M, Kaila M, et al. A 10 year asthma programme in finland: major change for the better. Thorax. 2006;61(8):663.<pub-id pub-id-type="pmid">16877690</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/thx.2005.055699</pub-id><pub-id pub-id-type="pmcid">PMC2104683</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR37"><label>37.</label><citation-alternatives><element-citation id="ec-CR37" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>James</surname><given-names>AL</given-names></name><name name-style="western"><surname>Palmer</surname><given-names>LJ</given-names></name><name name-style="western"><surname>Kicic</surname><given-names>E</given-names></name><name name-style="western"><surname>Maxwell</surname><given-names>PS</given-names></name><name name-style="western"><surname>Lagan</surname><given-names>SE</given-names></name><name name-style="western"><surname>Ryan</surname><given-names>GF</given-names></name><etal/></person-group><article-title>Decline in lung function in the Busselton health study: the effects of asthma and cigarette smoking</article-title><source>Am J Respir Crit Care Med</source><year>2005</year><volume>171</volume><issue>2</issue><fpage>109</fpage><lpage>14</lpage><pub-id pub-id-type="pmid">15486340</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1164/rccm.200402-230OC</pub-id></element-citation><mixed-citation id="mc-CR37" publication-type="journal">James AL, Palmer LJ, Kicic E, Maxwell PS, Lagan SE, Ryan GF, et al. Decline in lung function in the Busselton health study: the effects of asthma and cigarette smoking. Am J Respir Crit Care Med. 2005;171(2):109&#8211;14.<pub-id pub-id-type="pmid">15486340</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1164/rccm.200402-230OC</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR38"><label>38.</label><citation-alternatives><element-citation id="ec-CR38" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jang</surname><given-names>AS</given-names></name><name name-style="western"><surname>Park</surname><given-names>JS</given-names></name><name name-style="western"><surname>Lee</surname><given-names>JH</given-names></name><name name-style="western"><surname>Park</surname><given-names>SW</given-names></name><name name-style="western"><surname>Kim</surname><given-names>DJ</given-names></name><name name-style="western"><surname>Uh</surname><given-names>ST</given-names></name><etal/></person-group><article-title>The impact of smoking on clinical and therapeutic effects in asthmatics</article-title><source>J Korean Med Sci</source><year>2009</year><volume>24</volume><issue>2</issue><fpage>209</fpage><lpage>14</lpage><pub-id pub-id-type="pmid">19399260</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3346/jkms.2009.24.2.209</pub-id><pub-id pub-id-type="pmcid">PMC2672118</pub-id></element-citation><mixed-citation id="mc-CR38" publication-type="journal">Jang AS, Park JS, Lee JH, Park SW, Kim DJ, Uh ST, et al. The impact of smoking on clinical and therapeutic effects in asthmatics. J Korean Med Sci. 2009;24(2):209&#8211;14.<pub-id pub-id-type="pmid">19399260</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3346/jkms.2009.24.2.209</pub-id><pub-id pub-id-type="pmcid">PMC2672118</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR39"><label>39.</label><citation-alternatives><element-citation id="ec-CR39" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Patel</surname><given-names>SN</given-names></name><name name-style="western"><surname>Tsai</surname><given-names>CL</given-names></name><name name-style="western"><surname>Boudreaux</surname><given-names>ED</given-names></name><name name-style="western"><surname>Kilgannon</surname><given-names>JH</given-names></name><name name-style="western"><surname>Sullivan</surname><given-names>AF</given-names></name><name name-style="western"><surname>Blumenthal</surname><given-names>D</given-names></name><etal/></person-group><article-title>Multicenter study of cigarette smoking among patients presenting to the emergency department with acute asthma</article-title><source>Ann Allergy Asthma Immunol</source><year>2009</year><volume>103</volume><issue>2</issue><fpage>121</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">19739424</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/S1081-1206(10)60164-0</pub-id></element-citation><mixed-citation id="mc-CR39" publication-type="journal">Patel SN, Tsai CL, Boudreaux ED, Kilgannon JH, Sullivan AF, Blumenthal D, et al. Multicenter study of cigarette smoking among patients presenting to the emergency department with acute asthma. Ann Allergy Asthma Immunol. 2009;103(2):121&#8211;7.<pub-id pub-id-type="pmid">19739424</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/S1081-1206(10)60164-0</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR40"><label>40.</label><citation-alternatives><element-citation id="ec-CR40" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Thomson</surname><given-names>NC</given-names></name><name name-style="western"><surname>Polosa</surname><given-names>R</given-names></name><name name-style="western"><surname>Sin</surname><given-names>DD</given-names></name></person-group><article-title>Cigarette smoking and asthma</article-title><source>J Allergy Clin Immunology: Pract</source><year>2022</year><volume>10</volume><issue>11</issue><fpage>2783</fpage><lpage>97</lpage><pub-id pub-id-type="pmid">35533997</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jaip.2022.04.034</pub-id></element-citation><mixed-citation id="mc-CR40" publication-type="journal">Thomson NC, Polosa R, Sin DD. Cigarette smoking and asthma. J Allergy Clin Immunology: Pract. 2022;10(11):2783&#8211;97.<pub-id pub-id-type="pmid">35533997</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jaip.2022.04.034</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR41"><label>41.</label><citation-alternatives><element-citation id="ec-CR41" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Polosa</surname><given-names>R</given-names></name><name name-style="western"><surname>Russo</surname><given-names>C</given-names></name><name name-style="western"><surname>Caponnetto</surname><given-names>P</given-names></name><name name-style="western"><surname>Bertino</surname><given-names>G</given-names></name><name name-style="western"><surname>Sarv&#224;</surname><given-names>M</given-names></name><name name-style="western"><surname>Antic</surname><given-names>T</given-names></name><etal/></person-group><article-title>Greater severity of new onset asthma in allergic subjects who smoke: a 10-year longitudinal study</article-title><source>Respir Res</source><year>2011</year><volume>12</volume><issue>1</issue><fpage>16</fpage><pub-id pub-id-type="pmid">21261960</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/1465-9921-12-16</pub-id><pub-id pub-id-type="pmcid">PMC3037316</pub-id></element-citation><mixed-citation id="mc-CR41" publication-type="journal">Polosa R, Russo C, Caponnetto P, Bertino G, Sarv&#224; M, Antic T, et al. Greater severity of new onset asthma in allergic subjects who smoke: a 10-year longitudinal study. Respir Res. 2011;12(1):16.<pub-id pub-id-type="pmid">21261960</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/1465-9921-12-16</pub-id><pub-id pub-id-type="pmcid">PMC3037316</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR42"><label>42.</label><citation-alternatives><element-citation id="ec-CR42" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lin</surname><given-names>H</given-names></name><name name-style="western"><surname>Li</surname><given-names>H</given-names></name></person-group><article-title>How does cigarette smoking affect airway remodeling in asthmatics?</article-title><source>Tob Induc Dis</source><year>2023</year><volume>21</volume><fpage>13</fpage><pub-id pub-id-type="pmid">36741543</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.18332/tid/156047</pub-id><pub-id pub-id-type="pmcid">PMC9881586</pub-id></element-citation><mixed-citation id="mc-CR42" publication-type="journal">Lin H, Li H. How does cigarette smoking affect airway remodeling in asthmatics? Tob Induc Dis. 2023;21:13.<pub-id pub-id-type="pmid">36741543</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.18332/tid/156047</pub-id><pub-id pub-id-type="pmcid">PMC9881586</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR43"><label>43.</label><citation-alternatives><element-citation id="ec-CR43" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dey</surname><given-names>S</given-names></name><name name-style="western"><surname>Lu</surname><given-names>W</given-names></name><name name-style="western"><surname>Weber</surname><given-names>HC</given-names></name><name name-style="western"><surname>Young</surname><given-names>S</given-names></name><name name-style="western"><surname>Larby</surname><given-names>J</given-names></name><name name-style="western"><surname>Chia</surname><given-names>C</given-names></name><etal/></person-group><article-title>Differential airway remodeling changes were observed in patients with asthma COPD overlap compared to patients with asthma and COPD alone</article-title><source>Am J Physiol Lung Cell Mol Physiol</source><year>2022</year><volume>323</volume><issue>4</issue><fpage>L473</fpage><lpage>83</lpage><pub-id pub-id-type="pmid">35997281</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1152/ajplung.00137.2022</pub-id><pub-id pub-id-type="pmcid">PMC9550567</pub-id></element-citation><mixed-citation id="mc-CR43" publication-type="journal">Dey S, Lu W, Weber HC, Young S, Larby J, Chia C, et al. Differential airway remodeling changes were observed in patients with asthma COPD overlap compared to patients with asthma and COPD alone. Am J Physiol Lung Cell Mol Physiol. 2022;323(4):L473&#8211;83.<pub-id pub-id-type="pmid">35997281</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1152/ajplung.00137.2022</pub-id><pub-id pub-id-type="pmcid">PMC9550567</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR44"><label>44.</label><citation-alternatives><element-citation id="ec-CR44" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dey</surname><given-names>S</given-names></name><name name-style="western"><surname>Eapen</surname><given-names>MS</given-names></name><name name-style="western"><surname>Chia</surname><given-names>C</given-names></name><name name-style="western"><surname>Gaikwad</surname><given-names>AV</given-names></name><name name-style="western"><surname>Wark</surname><given-names>PAB</given-names></name><name name-style="western"><surname>Sohal</surname><given-names>SS</given-names></name></person-group><article-title>Pathogenesis, clinical features of asthma COPD overlap, and therapeutic modalities</article-title><source>Am J Physiology-Lung Cell Mol Physiol</source><year>2021</year><volume>322</volume><issue>1</issue><fpage>L64</fpage><lpage>83</lpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.1152/ajplung.00121.2021</pub-id><pub-id pub-id-type="pmid">34668439</pub-id></element-citation><mixed-citation id="mc-CR44" publication-type="journal">Dey S, Eapen MS, Chia C, Gaikwad AV, Wark PAB, Sohal SS. Pathogenesis, clinical features of asthma COPD overlap, and therapeutic modalities. Am J Physiology-Lung Cell Mol Physiol. 2021;322(1):L64&#8211;83.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1152/ajplung.00121.2021</pub-id><pub-id pub-id-type="pmid">34668439</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR45"><label>45.</label><citation-alternatives><element-citation id="ec-CR45" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dey</surname><given-names>S</given-names></name><name name-style="western"><surname>Lu</surname><given-names>W</given-names></name><name name-style="western"><surname>Pathinayake</surname><given-names>PS</given-names></name><name name-style="western"><surname>Waters</surname><given-names>M</given-names></name><name name-style="western"><surname>Haug</surname><given-names>G</given-names></name><name name-style="western"><surname>Larby</surname><given-names>J</given-names></name><etal/></person-group><article-title>Epithelial-to-mesenchymal transition is an active process in the large airways of patients with asthma-COPD overlap and partially abrogated by inhaled corticosteroid treatment: a bronchoscopy endobronchial biopsy study</article-title><source>Front Immunol</source><year>2025</year><volume>16</volume><fpage>1531279</fpage><pub-id pub-id-type="pmid">40475784</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fimmu.2025.1531279</pub-id><pub-id pub-id-type="pmcid">PMC12137101</pub-id></element-citation><mixed-citation id="mc-CR45" publication-type="journal">Dey S, Lu W, Pathinayake PS, Waters M, Haug G, Larby J, et al. Epithelial-to-mesenchymal transition is an active process in the large airways of patients with asthma-COPD overlap and partially abrogated by inhaled corticosteroid treatment: a bronchoscopy endobronchial biopsy study. Front Immunol. 2025;16:1531279.<pub-id pub-id-type="pmid">40475784</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fimmu.2025.1531279</pub-id><pub-id pub-id-type="pmcid">PMC12137101</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR46"><label>46.</label><citation-alternatives><element-citation id="ec-CR46" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sohal</surname><given-names>SS</given-names></name></person-group><article-title>Vascular pruning in smokers, patients with small airway disease and early COPD</article-title><source>Am J Respir Crit Care Med</source><year>2025</year><volume>211</volume><issue>5</issue><fpage>885</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">40020240</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1164/rccm.202411-2325LE</pub-id><pub-id pub-id-type="pmcid">PMC12091000</pub-id></element-citation><mixed-citation id="mc-CR46" publication-type="journal">Sohal SS. Vascular pruning in smokers, patients with small airway disease and early COPD. Am J Respir Crit Care Med. 2025;211(5):885&#8211;6.<pub-id pub-id-type="pmid">40020240</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1164/rccm.202411-2325LE</pub-id><pub-id pub-id-type="pmcid">PMC12091000</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR47"><label>47.</label><mixed-citation publication-type="other">Dey S, Lu W, Weber HC, Chia C, Pathinayake PS, Wark PAB et al. Large airway wall vascularity in patients with asthma-COPD overlap: a bronchoscopy study. ERJ Open Res. 2024;10(4).<pub-id pub-id-type="doi" assigning-authority="pmc">10.1183/23120541.00002-2024</pub-id><pub-id pub-id-type="pmcid">PMC11228595</pub-id><pub-id pub-id-type="pmid">38978556</pub-id></mixed-citation></ref><ref id="CR48"><label>48.</label><citation-alternatives><element-citation id="ec-CR48" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sun</surname><given-names>J</given-names></name><name name-style="western"><surname>Xi</surname><given-names>B</given-names></name><name name-style="western"><surname>Ma</surname><given-names>C</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>M</given-names></name><name name-style="western"><surname>Bovet</surname><given-names>P</given-names></name></person-group><article-title>Prevalence of E-Cigarette use and its associated factors among youths aged 12 to 16 years in 68 countries and territories: global youth tobacco survey, 2012&#8211;2019</article-title><source>Am J Public Health</source><year>2022</year><volume>112</volume><issue>4</issue><fpage>650</fpage><lpage>61</lpage><pub-id pub-id-type="pmid">35319939</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2105/AJPH.2021.306686</pub-id><pub-id pub-id-type="pmcid">PMC8961851</pub-id></element-citation><mixed-citation id="mc-CR48" publication-type="journal">Sun J, Xi B, Ma C, Zhao M, Bovet P. Prevalence of E-Cigarette use and its associated factors among youths aged 12 to 16 years in 68 countries and territories: global youth tobacco survey, 2012&#8211;2019. Am J Public Health. 2022;112(4):650&#8211;61.<pub-id pub-id-type="pmid">35319939</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2105/AJPH.2021.306686</pub-id><pub-id pub-id-type="pmcid">PMC8961851</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR49"><label>49.</label><citation-alternatives><element-citation id="ec-CR49" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tam</surname><given-names>J</given-names></name><name name-style="western"><surname>Brouwer</surname><given-names>AF</given-names></name></person-group><article-title>Comparison of e-cigarette use prevalence and frequency by smoking status among youth in the united states, 2014&#8211;19</article-title><source>Addiction</source><year>2021</year><volume>116</volume><issue>9</issue><fpage>2486</fpage><lpage>97</lpage><pub-id pub-id-type="pmid">33565662</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/add.15439</pub-id><pub-id pub-id-type="pmcid">PMC8328922</pub-id></element-citation><mixed-citation id="mc-CR49" publication-type="journal">Tam J, Brouwer AF. Comparison of e-cigarette use prevalence and frequency by smoking status among youth in the united states, 2014&#8211;19. Addiction. 2021;116(9):2486&#8211;97.<pub-id pub-id-type="pmid">33565662</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/add.15439</pub-id><pub-id pub-id-type="pmcid">PMC8328922</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR50"><label>50.</label><citation-alternatives><element-citation id="ec-CR50" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>McAlinden</surname><given-names>KD</given-names></name><name name-style="western"><surname>Eapen</surname><given-names>MS</given-names></name><name name-style="western"><surname>Lu</surname><given-names>W</given-names></name><name name-style="western"><surname>Sharma</surname><given-names>P</given-names></name><name name-style="western"><surname>Sohal</surname><given-names>SS</given-names></name></person-group><article-title>The rise of electronic nicotine delivery systems and the emergence of electronic-cigarette-driven disease</article-title><source>Am J Physiology-Lung Cell Mol Physiol</source><year>2020</year><volume>319</volume><issue>4</issue><fpage>L585</fpage><lpage>95</lpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.1152/ajplung.00160.2020</pub-id><pub-id pub-id-type="pmid">32726146</pub-id></element-citation><mixed-citation id="mc-CR50" publication-type="journal">McAlinden KD, Eapen MS, Lu W, Sharma P, Sohal SS. The rise of electronic nicotine delivery systems and the emergence of electronic-cigarette-driven disease. Am J Physiology-Lung Cell Mol Physiol. 2020;319(4):L585&#8211;95.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1152/ajplung.00160.2020</pub-id><pub-id pub-id-type="pmid">32726146</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR51"><label>51.</label><citation-alternatives><element-citation id="ec-CR51" publication-type="book"><person-group person-group-type="author"><collab>National Academies of Sciences E, and Medicine</collab></person-group><source>Committee on the review of the health effects of electronic cigarettes of electronic nicotine delivery systems</source><year>2018</year><publisher-loc>Washington, DC</publisher-loc><publisher-name>National Academies</publisher-name><fpage>680</fpage></element-citation><mixed-citation id="mc-CR51" publication-type="book">National Academies of Sciences E, and Medicine. Committee on the review of the health effects of electronic cigarettes of electronic nicotine delivery systems. Washington, DC: National Academies; 2018. p. 680.</mixed-citation></citation-alternatives></ref><ref id="CR52"><label>52.</label><citation-alternatives><element-citation id="ec-CR52" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schweitzer</surname><given-names>RJ</given-names></name><name name-style="western"><surname>Wills</surname><given-names>TA</given-names></name><name name-style="western"><surname>Tam</surname><given-names>E</given-names></name><name name-style="western"><surname>Pagano</surname><given-names>I</given-names></name><name name-style="western"><surname>Choi</surname><given-names>K</given-names></name></person-group><article-title>E-cigarette use and asthma in a multiethnic sample of adolescents</article-title><source>Prev Med</source><year>2017</year><volume>105</volume><fpage>226</fpage><lpage>31</lpage><pub-id pub-id-type="pmid">28964850</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.ypmed.2017.09.023</pub-id><pub-id pub-id-type="pmcid">PMC5653431</pub-id></element-citation><mixed-citation id="mc-CR52" publication-type="journal">Schweitzer RJ, Wills TA, Tam E, Pagano I, Choi K. E-cigarette use and asthma in a multiethnic sample of adolescents. Prev Med. 2017;105:226&#8211;31.<pub-id pub-id-type="pmid">28964850</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.ypmed.2017.09.023</pub-id><pub-id pub-id-type="pmcid">PMC5653431</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR53"><label>53.</label><citation-alternatives><element-citation id="ec-CR53" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Taghrid</surname><given-names>A</given-names></name><name name-style="western"><surname>Rime</surname><given-names>J</given-names></name><name name-style="western"><surname>Wei</surname><given-names>L</given-names></name><name name-style="western"><surname>Olusanya Joshua</surname><given-names>O</given-names></name><name name-style="western"><surname>Tarana</surname><given-names>F</given-names></name><name name-style="western"><surname>Prem</surname><given-names>G</given-names></name><etal/></person-group><article-title>Risk and safety profile of electronic nicotine delivery systems (ENDS): an umbrella review to inform ENDS health communication strategies</article-title><source>Tob Control</source><year>2024</year><volume>33</volume><issue>3</issue><fpage>373</fpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/tc-2022-057495</pub-id><pub-id pub-id-type="pmcid">PMC10043882</pub-id><pub-id pub-id-type="pmid">36252567</pub-id></element-citation><mixed-citation id="mc-CR53" publication-type="journal">Taghrid A, Rime J, Wei L, Olusanya Joshua O, Tarana F, Prem G, et al. Risk and safety profile of electronic nicotine delivery systems (ENDS): an umbrella review to inform ENDS health communication strategies. Tob Control. 2024;33(3):373.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/tc-2022-057495</pub-id><pub-id pub-id-type="pmcid">PMC10043882</pub-id><pub-id pub-id-type="pmid">36252567</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR54"><label>54.</label><citation-alternatives><element-citation id="ec-CR54" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Alnajem</surname><given-names>A</given-names></name><name name-style="western"><surname>Redha</surname><given-names>A</given-names></name><name name-style="western"><surname>Alroumi</surname><given-names>D</given-names></name><name name-style="western"><surname>Alshammasi</surname><given-names>A</given-names></name><name name-style="western"><surname>Ali</surname><given-names>M</given-names></name><name name-style="western"><surname>Alhussaini</surname><given-names>M</given-names></name><etal/></person-group><article-title>Use of electronic cigarettes and secondhand exposure to their aerosols are associated with asthma symptoms among adolescents: a cross-sectional study</article-title><source>Respir Res</source><year>2020</year><volume>21</volume><issue>1</issue><fpage>300</fpage><pub-id pub-id-type="pmid">33198741</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s12931-020-01569-9</pub-id><pub-id pub-id-type="pmcid">PMC7670675</pub-id></element-citation><mixed-citation id="mc-CR54" publication-type="journal">Alnajem A, Redha A, Alroumi D, Alshammasi A, Ali M, Alhussaini M, et al. Use of electronic cigarettes and secondhand exposure to their aerosols are associated with asthma symptoms among adolescents: a cross-sectional study. Respir Res. 2020;21(1):300.<pub-id pub-id-type="pmid">33198741</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s12931-020-01569-9</pub-id><pub-id pub-id-type="pmcid">PMC7670675</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR55"><label>55.</label><citation-alternatives><element-citation id="ec-CR55" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bhatta</surname><given-names>DN</given-names></name><name name-style="western"><surname>Glantz</surname><given-names>SA</given-names></name></person-group><article-title>Association of E-Cigarette use with respiratory disease among adults: A longitudinal analysis</article-title><source>Am J Prev Med</source><year>2020</year><volume>58</volume><issue>2</issue><fpage>182</fpage><lpage>90</lpage><pub-id pub-id-type="pmid">31859175</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.amepre.2019.07.028</pub-id><pub-id pub-id-type="pmcid">PMC6981012</pub-id></element-citation><mixed-citation id="mc-CR55" publication-type="journal">Bhatta DN, Glantz SA. Association of E-Cigarette use with respiratory disease among adults: A longitudinal analysis. Am J Prev Med. 2020;58(2):182&#8211;90.<pub-id pub-id-type="pmid">31859175</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.amepre.2019.07.028</pub-id><pub-id pub-id-type="pmcid">PMC6981012</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR56"><label>56.</label><citation-alternatives><element-citation id="ec-CR56" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Xie</surname><given-names>W</given-names></name><name name-style="western"><surname>Tackett</surname><given-names>AP</given-names></name><name name-style="western"><surname>Berlowitz</surname><given-names>JB</given-names></name><name name-style="western"><surname>Harlow</surname><given-names>AF</given-names></name><name name-style="western"><surname>Kathuria</surname><given-names>H</given-names></name><name name-style="western"><surname>Galiatsatos</surname><given-names>P</given-names></name><etal/></person-group><article-title>Association of electronic cigarette use with respiratory symptom development among U.S. Young adults</article-title><source>Am J Respir Crit Care Med</source><year>2022</year><volume>205</volume><issue>11</issue><fpage>1320</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">35089853</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1164/rccm.202107-1718OC</pub-id><pub-id pub-id-type="pmcid">PMC9873120</pub-id></element-citation><mixed-citation id="mc-CR56" publication-type="journal">Xie W, Tackett AP, Berlowitz JB, Harlow AF, Kathuria H, Galiatsatos P, et al. Association of electronic cigarette use with respiratory symptom development among U.S. Young adults. Am J Respir Crit Care Med. 2022;205(11):1320&#8211;9.<pub-id pub-id-type="pmid">35089853</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1164/rccm.202107-1718OC</pub-id><pub-id pub-id-type="pmcid">PMC9873120</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR57"><label>57.</label><citation-alternatives><element-citation id="ec-CR57" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Glantz Stanton</surname><given-names>A</given-names></name><name name-style="western"><surname>Nguyen</surname><given-names>N</given-names></name><name name-style="western"><surname>Oliveira da Silva Andre</surname><given-names>L</given-names></name></person-group><article-title>Population-Based disease odds for E-Cigarettes and dual use versus cigarettes</article-title><source>NEJM Evid</source><year>2024</year><volume>3</volume><issue>3</issue><fpage>EVIDoa2300229</fpage><pub-id pub-id-type="pmid">38411454</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1056/EVIDoa2300229</pub-id><pub-id pub-id-type="pmcid">PMC11562742</pub-id></element-citation><mixed-citation id="mc-CR57" publication-type="journal">Glantz Stanton A, Nguyen N, Oliveira da Silva Andre L. Population-Based disease odds for E-Cigarettes and dual use versus cigarettes. NEJM Evid. 2024;3(3):EVIDoa2300229.<pub-id pub-id-type="pmid">38411454</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1056/EVIDoa2300229</pub-id><pub-id pub-id-type="pmcid">PMC11562742</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR58"><label>58.</label><citation-alternatives><element-citation id="ec-CR58" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hedman</surname><given-names>L</given-names></name><name name-style="western"><surname>Backman</surname><given-names>H</given-names></name><name name-style="western"><surname>Stridsman</surname><given-names>C</given-names></name><name name-style="western"><surname>Bosson</surname><given-names>JA</given-names></name><name name-style="western"><surname>Lundb&#228;ck</surname><given-names>M</given-names></name><name name-style="western"><surname>Lindberg</surname><given-names>A</given-names></name><etal/></person-group><article-title>Association of electronic cigarette use with smoking habits, demographic factors, and respiratory symptoms</article-title><source>JAMA Netw Open</source><year>2018</year><volume>1</volume><issue>3</issue><fpage>e180789</fpage><pub-id pub-id-type="pmid">30646032</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1001/jamanetworkopen.2018.0789</pub-id><pub-id pub-id-type="pmcid">PMC6324524</pub-id></element-citation><mixed-citation id="mc-CR58" publication-type="journal">Hedman L, Backman H, Stridsman C, Bosson JA, Lundb&#228;ck M, Lindberg A, et al. Association of electronic cigarette use with smoking habits, demographic factors, and respiratory symptoms. JAMA Netw Open. 2018;1(3):e180789.<pub-id pub-id-type="pmid">30646032</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1001/jamanetworkopen.2018.0789</pub-id><pub-id pub-id-type="pmcid">PMC6324524</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR59"><label>59.</label><citation-alternatives><element-citation id="ec-CR59" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>D</given-names></name><name name-style="western"><surname>Sundar</surname><given-names>IK</given-names></name><name name-style="western"><surname>McIntosh</surname><given-names>S</given-names></name><name name-style="western"><surname>Ossip</surname><given-names>DJ</given-names></name><name name-style="western"><surname>Goniewicz</surname><given-names>ML</given-names></name><name name-style="western"><surname>O&#8217;Connor</surname><given-names>RJ</given-names></name><etal/></person-group><article-title>Association of smoking and electronic cigarette use with wheezing and related respiratory symptoms in adults: cross-sectional results from the population assessment of tobacco and health (PATH) study, wave 2</article-title><source>Tob Control</source><year>2020</year><volume>29</volume><issue>2</issue><fpage>140</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">30760629</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/tobaccocontrol-2018-054694</pub-id><pub-id pub-id-type="pmcid">PMC6692241</pub-id></element-citation><mixed-citation id="mc-CR59" publication-type="journal">Li D, Sundar IK, McIntosh S, Ossip DJ, Goniewicz ML, O&#8217;Connor RJ, et al. Association of smoking and electronic cigarette use with wheezing and related respiratory symptoms in adults: cross-sectional results from the population assessment of tobacco and health (PATH) study, wave 2. Tob Control. 2020;29(2):140&#8211;7.<pub-id pub-id-type="pmid">30760629</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/tobaccocontrol-2018-054694</pub-id><pub-id pub-id-type="pmcid">PMC6692241</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR60"><label>60.</label><citation-alternatives><element-citation id="ec-CR60" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chalmers</surname><given-names>GW</given-names></name><name name-style="western"><surname>Macleod</surname><given-names>KJ</given-names></name><name name-style="western"><surname>Little</surname><given-names>SA</given-names></name><name name-style="western"><surname>Thomson</surname><given-names>LJ</given-names></name><name name-style="western"><surname>McSharry</surname><given-names>CP</given-names></name><name name-style="western"><surname>Thomson</surname><given-names>NC</given-names></name></person-group><article-title>Influence of cigarette smoking on inhaled corticosteroid treatment in mild asthma</article-title><source>Thorax</source><year>2002</year><volume>57</volume><issue>3</issue><fpage>226</fpage><pub-id pub-id-type="pmid">11867826</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/thorax.57.3.226</pub-id><pub-id pub-id-type="pmcid">PMC1746270</pub-id></element-citation><mixed-citation id="mc-CR60" publication-type="journal">Chalmers GW, Macleod KJ, Little SA, Thomson LJ, McSharry CP, Thomson NC. Influence of cigarette smoking on inhaled corticosteroid treatment in mild asthma. Thorax. 2002;57(3):226.<pub-id pub-id-type="pmid">11867826</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/thorax.57.3.226</pub-id><pub-id pub-id-type="pmcid">PMC1746270</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR61"><label>61.</label><citation-alternatives><element-citation id="ec-CR61" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lazarus</surname><given-names>SC</given-names></name><name name-style="western"><surname>Chinchilli</surname><given-names>VM</given-names></name><name name-style="western"><surname>Rollings</surname><given-names>NJ</given-names></name><name name-style="western"><surname>Boushey</surname><given-names>HA</given-names></name><name name-style="western"><surname>Cherniack</surname><given-names>R</given-names></name><name name-style="western"><surname>Craig</surname><given-names>TJ</given-names></name><etal/></person-group><article-title>Smoking affects response to inhaled corticosteroids or leukotriene receptor antagonists in asthma</article-title><source>Am J Respir Crit Care Med</source><year>2007</year><volume>175</volume><issue>8</issue><fpage>783</fpage><lpage>90</lpage><pub-id pub-id-type="pmid">17204725</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1164/rccm.200511-1746OC</pub-id><pub-id pub-id-type="pmcid">PMC1899291</pub-id></element-citation><mixed-citation id="mc-CR61" publication-type="journal">Lazarus SC, Chinchilli VM, Rollings NJ, Boushey HA, Cherniack R, Craig TJ, et al. Smoking affects response to inhaled corticosteroids or leukotriene receptor antagonists in asthma. Am J Respir Crit Care Med. 2007;175(8):783&#8211;90.<pub-id pub-id-type="pmid">17204725</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1164/rccm.200511-1746OC</pub-id><pub-id pub-id-type="pmcid">PMC1899291</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR62"><label>62.</label><citation-alternatives><element-citation id="ec-CR62" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Spears</surname><given-names>M</given-names></name><name name-style="western"><surname>Cameron</surname><given-names>E</given-names></name><name name-style="western"><surname>Chaudhuri</surname><given-names>R</given-names></name><name name-style="western"><surname>Thomson</surname><given-names>NC</given-names></name></person-group><article-title>Challenges of treating asthma in people who smoke</article-title><source>Expert Rev Clin Immunol</source><year>2010</year><volume>6</volume><issue>2</issue><fpage>257</fpage><lpage>68</lpage><pub-id pub-id-type="pmid">20402388</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1586/eci.09.85</pub-id></element-citation><mixed-citation id="mc-CR62" publication-type="journal">Spears M, Cameron E, Chaudhuri R, Thomson NC. Challenges of treating asthma in people who smoke. Expert Rev Clin Immunol. 2010;6(2):257&#8211;68.<pub-id pub-id-type="pmid">20402388</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1586/eci.09.85</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR63"><label>63.</label><citation-alternatives><element-citation id="ec-CR63" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Thomson</surname><given-names>NC</given-names></name><name name-style="western"><surname>Chaudhuri</surname><given-names>R</given-names></name></person-group><article-title>Asthma in smokers: challenges and opportunities</article-title><source>Curr Opin Pulm Med</source><year>2009</year><volume>15</volume><issue>1</issue><fpage>39</fpage><lpage>45</lpage><pub-id pub-id-type="pmid">19077704</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/MCP.0b013e32831da894</pub-id></element-citation><mixed-citation id="mc-CR63" publication-type="journal">Thomson NC, Chaudhuri R. Asthma in smokers: challenges and opportunities. Curr Opin Pulm Med. 2009;15(1):39&#8211;45.<pub-id pub-id-type="pmid">19077704</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/MCP.0b013e32831da894</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR64"><label>64.</label><citation-alternatives><element-citation id="ec-CR64" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Barnes</surname><given-names>PJ</given-names></name><name name-style="western"><surname>Pedersen</surname><given-names>S</given-names></name><name name-style="western"><surname>Busse</surname><given-names>WW</given-names></name></person-group><article-title>Efficacy and safety of inhaled corticosteroids</article-title><source>Am J Respir Crit Care Med</source><year>1998</year><volume>157</volume><issue>3</issue><fpage>S1</fpage><lpage>53</lpage><pub-id pub-id-type="pmid">9520807</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1164/ajrccm.157.3.157315</pub-id></element-citation><mixed-citation id="mc-CR64" publication-type="journal">Barnes PJ, Pedersen S, Busse WW. Efficacy and safety of inhaled corticosteroids. Am J Respir Crit Care Med. 1998;157(3):S1&#8211;53.<pub-id pub-id-type="pmid">9520807</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1164/ajrccm.157.3.157315</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR65"><label>65.</label><citation-alternatives><element-citation id="ec-CR65" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tomlinson</surname><given-names>JEM</given-names></name><name name-style="western"><surname>McMahon</surname><given-names>AD</given-names></name><name name-style="western"><surname>Chaudhuri</surname><given-names>R</given-names></name><name name-style="western"><surname>Thompson</surname><given-names>JM</given-names></name><name name-style="western"><surname>Wood</surname><given-names>SF</given-names></name><name name-style="western"><surname>Thomson</surname><given-names>NC</given-names></name></person-group><article-title>Efficacy of low and high dose inhaled corticosteroid in smokers versus non-smokers with mild asthma</article-title><source>Thorax</source><year>2005</year><volume>60</volume><issue>4</issue><fpage>282</fpage><pub-id pub-id-type="pmid">15790982</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/thx.2004.033688</pub-id><pub-id pub-id-type="pmcid">PMC1747368</pub-id></element-citation><mixed-citation id="mc-CR65" publication-type="journal">Tomlinson JEM, McMahon AD, Chaudhuri R, Thompson JM, Wood SF, Thomson NC. Efficacy of low and high dose inhaled corticosteroid in smokers versus non-smokers with mild asthma. Thorax. 2005;60(4):282.<pub-id pub-id-type="pmid">15790982</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/thx.2004.033688</pub-id><pub-id pub-id-type="pmcid">PMC1747368</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR66"><label>66.</label><citation-alternatives><element-citation id="ec-CR66" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chaudhuri</surname><given-names>R</given-names></name><name name-style="western"><surname>Livingston</surname><given-names>E</given-names></name><name name-style="western"><surname>McMahon</surname><given-names>AD</given-names></name><name name-style="western"><surname>Lafferty</surname><given-names>J</given-names></name><name name-style="western"><surname>Fraser</surname><given-names>I</given-names></name><name name-style="western"><surname>Spears</surname><given-names>M</given-names></name><etal/></person-group><article-title>Effects of smoking cessation on lung function and airway inflammation in smokers with asthma</article-title><source>Am J Respir Crit Care Med</source><year>2006</year><volume>174</volume><issue>2</issue><fpage>127</fpage><lpage>33</lpage><pub-id pub-id-type="pmid">16645173</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1164/rccm.200510-1589OC</pub-id></element-citation><mixed-citation id="mc-CR66" publication-type="journal">Chaudhuri R, Livingston E, McMahon AD, Lafferty J, Fraser I, Spears M, et al. Effects of smoking cessation on lung function and airway inflammation in smokers with asthma. Am J Respir Crit Care Med. 2006;174(2):127&#8211;33.<pub-id pub-id-type="pmid">16645173</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1164/rccm.200510-1589OC</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR67"><label>67.</label><citation-alternatives><element-citation id="ec-CR67" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>T&#248;nnesen</surname><given-names>P</given-names></name><name name-style="western"><surname>Pisinger</surname><given-names>C</given-names></name><name name-style="western"><surname>Hvidberg</surname><given-names>S</given-names></name><name name-style="western"><surname>Wennike</surname><given-names>P</given-names></name><name name-style="western"><surname>Bremann</surname><given-names>L</given-names></name><name name-style="western"><surname>Westin</surname><given-names>&#197;</given-names></name><etal/></person-group><article-title>Effects of smoking cessation and reduction in asthmatics</article-title><source>Nicotine Tob Res</source><year>2005</year><volume>7</volume><issue>1</issue><fpage>139</fpage><lpage>48</lpage><pub-id pub-id-type="pmid">15804686</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1080/14622200412331328411</pub-id></element-citation><mixed-citation id="mc-CR67" publication-type="journal">T&#248;nnesen P, Pisinger C, Hvidberg S, Wennike P, Bremann L, Westin &#197;, et al. Effects of smoking cessation and reduction in asthmatics. Nicotine Tob Res. 2005;7(1):139&#8211;48.<pub-id pub-id-type="pmid">15804686</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1080/14622200412331328411</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR68"><label>68.</label><citation-alternatives><element-citation id="ec-CR68" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Westergaard</surname><given-names>CG</given-names></name><name name-style="western"><surname>Porsbjerg</surname><given-names>C</given-names></name><name name-style="western"><surname>Backer</surname><given-names>V</given-names></name></person-group><article-title>The effect of smoking cessation on airway inflammation in young asthma patients</article-title><source>Clin Experimental Allergy</source><year>2014</year><volume>44</volume><issue>3</issue><fpage>353</fpage><lpage>61</lpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/cea.12243</pub-id><pub-id pub-id-type="pmid">24286379</pub-id></element-citation><mixed-citation id="mc-CR68" publication-type="journal">Westergaard CG, Porsbjerg C, Backer V. The effect of smoking cessation on airway inflammation in young asthma patients. Clin Experimental Allergy. 2014;44(3):353&#8211;61.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/cea.12243</pub-id><pub-id pub-id-type="pmid">24286379</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR69"><label>69.</label><citation-alternatives><element-citation id="ec-CR69" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Thomson</surname><given-names>NC</given-names></name><name name-style="western"><surname>Chaudhuri</surname><given-names>R</given-names></name><name name-style="western"><surname>Heaney</surname><given-names>LG</given-names></name><name name-style="western"><surname>Bucknall</surname><given-names>C</given-names></name><name name-style="western"><surname>Niven</surname><given-names>RM</given-names></name><name name-style="western"><surname>Brightling</surname><given-names>CE</given-names></name><etal/></person-group><article-title>Clinical outcomes and inflammatory biomarkers in current smokers and exsmokers with severe asthma</article-title><source>J Allergy Clin Immunol</source><year>2013</year><volume>131</volume><issue>4</issue><fpage>1008</fpage><lpage>16</lpage><pub-id pub-id-type="pmid">23419540</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jaci.2012.12.1574</pub-id></element-citation><mixed-citation id="mc-CR69" publication-type="journal">Thomson NC, Chaudhuri R, Heaney LG, Bucknall C, Niven RM, Brightling CE, et al. Clinical outcomes and inflammatory biomarkers in current smokers and exsmokers with severe asthma. J Allergy Clin Immunol. 2013;131(4):1008&#8211;16.<pub-id pub-id-type="pmid">23419540</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jaci.2012.12.1574</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR70"><label>70.</label><citation-alternatives><element-citation id="ec-CR70" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Caponnetto</surname><given-names>P</given-names></name><name name-style="western"><surname>Polosa</surname><given-names>R</given-names></name><name name-style="western"><surname>Best</surname><given-names>D</given-names></name></person-group><article-title>Tobacco use cessation counseling of parents</article-title><source>Curr Opin Pediatr</source><year>2008</year><volume>20</volume><issue>6</issue><fpage>729</fpage><lpage>33</lpage><pub-id pub-id-type="pmid">19023920</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/mop.0b013e328317f1d2</pub-id></element-citation><mixed-citation id="mc-CR70" publication-type="journal">Caponnetto P, Polosa R, Best D. Tobacco use cessation counseling of parents. Curr Opin Pediatr. 2008;20(6):729&#8211;33.<pub-id pub-id-type="pmid">19023920</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/mop.0b013e328317f1d2</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR71"><label>71.</label><mixed-citation publication-type="other">WHO report on the global tobacco epidemic. 2008: the MPOWER package: Geneva: World Health Organization; 2008 [Available from: <ext-link ext-link-type="uri" xlink:href="https://iris.who.int/handle/10665/43818">https://iris.who.int/handle/10665/43818</ext-link></mixed-citation></ref><ref id="CR72"><label>72.</label><citation-alternatives><element-citation id="ec-CR72" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>McHardy</surname><given-names>J</given-names></name><name name-style="western"><surname>Marquizo</surname><given-names>AB</given-names></name><name name-style="western"><surname>Bettcher</surname><given-names>D</given-names></name><name name-style="western"><surname>Gakidou</surname><given-names>E</given-names></name></person-group><article-title>Policy view: worldwide patterns of tobacco use with recommendations for tobacco control</article-title><source>Lancet Respir Med</source><year>2025</year><volume>13</volume><issue>8</issue><fpage>756</fpage><lpage>68</lpage><pub-id pub-id-type="pmid">40684783</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/S2213-2600(25)00172-9</pub-id></element-citation><mixed-citation id="mc-CR72" publication-type="journal">McHardy J, Marquizo AB, Bettcher D, Gakidou E. Policy view: worldwide patterns of tobacco use with recommendations for tobacco control. Lancet Respir Med. 2025;13(8):756&#8211;68.<pub-id pub-id-type="pmid">40684783</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/S2213-2600(25)00172-9</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR73"><label>73.</label><citation-alternatives><element-citation id="ec-CR73" publication-type="book"><person-group person-group-type="author"><collab>WHO Package of Essential Noncomunicable (PEN)</collab></person-group><source>Disease interventions for primary health care</source><year>2020</year><publisher-loc>Geneva</publisher-loc><publisher-name>World Health Organization</publisher-name></element-citation><mixed-citation id="mc-CR73" publication-type="book">WHO Package of Essential Noncomunicable (PEN). Disease interventions for primary health care. Geneva: World Health Organization; 2020.</mixed-citation></citation-alternatives></ref><ref id="CR74"><label>74.</label><mixed-citation publication-type="other">McClure T. New Zealand passes world-first tobacco law to ban smoking for next generation. Guardian. 2022 13 Dec 2022.</mixed-citation></ref><ref id="CR75"><label>75.</label><mixed-citation publication-type="other">Ait Ouakrim D, Wilson T, Howe S, Clarke P, Gartner CE, Wilson N et al. Economic effects for citizens and the government of a country-level tobacco endgame strategy: a modelling study. Tob Control. 2023:tc&#8211;2023.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/tc-2023-058131</pub-id><pub-id pub-id-type="pmid">38050170</pub-id></mixed-citation></ref><ref id="CR76"><label>76.</label><citation-alternatives><element-citation id="ec-CR76" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Andrew</surname><given-names>A</given-names></name></person-group><article-title>New zealand&#8217;s world-first smokefree legislation &#8216;goes up in smoke&#8217;: A setback in ending the tobacco epidemic</article-title><source>Health Policy</source><year>2024</year><volume>147</volume><fpage>105123</fpage><pub-id pub-id-type="pmid">39018787</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.healthpol.2024.105123</pub-id></element-citation><mixed-citation id="mc-CR76" publication-type="journal">Andrew A. New zealand&#8217;s world-first smokefree legislation &#8216;goes up in smoke&#8217;: A setback in ending the tobacco epidemic. Health Policy. 2024;147:105123.<pub-id pub-id-type="pmid">39018787</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.healthpol.2024.105123</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR77"><label>77.</label><mixed-citation publication-type="other">Jackson SE, Shahab L, Brown J. The end of smoking in england?? The importance of considering different metrics of success. Tob Control. 2025:tc&#8211;2025.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/tc-2025-059469</pub-id><pub-id pub-id-type="pmid">40701804</pub-id></mixed-citation></ref><ref id="CR78"><label>78.</label><mixed-citation publication-type="other">Laverty A. Smoke-free generation legislation in the United Kingdom. Tobacco Prevention &amp; Cessation. 2024;10(Supplement 1).</mixed-citation></ref><ref id="CR79"><label>79.</label><mixed-citation publication-type="other">Willemsen M. Tobacco control policy in The Netherlands: A success story under threat. Tobacco Prevention &amp; Cessation. 2024;10(Supplement 1).</mixed-citation></ref><ref id="CR80"><label>80.</label><mixed-citation publication-type="other">McLoughlin RF, McDonald VM. The management of extrapulmonary comorbidities and treatable traits; obesity, physical inactivity, anxiety, and depression, in adults with asthma. Front Allergy. 2021;2.<pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/falgy.2021.735030</pub-id><pub-id pub-id-type="pmcid">PMC8974714</pub-id><pub-id pub-id-type="pmid">35387051</pub-id></mixed-citation></ref><ref id="CR81"><label>81.</label><mixed-citation publication-type="other">WHO global report on trends in prevalence of tobacco use 2000&#8211;2025, fourth edition: Geneva: World Health Organization. 2021 [Available from: <ext-link ext-link-type="uri" xlink:href="https://iris.who.int/handle/10665/348537">https://iris.who.int/handle/10665/348537</ext-link></mixed-citation></ref><ref id="CR82"><label>82.</label><mixed-citation publication-type="other">Urgent action needed. To protect children and prevent the uptake of e-cigarettes. WHO; 2023. 14 December 2023.</mixed-citation></ref><ref id="CR83"><label>83.</label><citation-alternatives><element-citation id="ec-CR83" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dove</surname><given-names>MS</given-names></name><name name-style="western"><surname>Dockery</surname><given-names>DW</given-names></name><name name-style="western"><surname>Connolly</surname><given-names>GN</given-names></name></person-group><article-title>Smoke-free air laws and asthma prevalence, symptoms, and severity among nonsmoking youth</article-title><source>Pediatrics</source><year>2011</year><volume>127</volume><issue>1</issue><fpage>102</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">21149426</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1542/peds.2010-1532</pub-id><pub-id pub-id-type="pmcid">PMC3375465</pub-id></element-citation><mixed-citation id="mc-CR83" publication-type="journal">Dove MS, Dockery DW, Connolly GN. Smoke-free air laws and asthma prevalence, symptoms, and severity among nonsmoking youth. Pediatrics. 2011;127(1):102&#8211;9.<pub-id pub-id-type="pmid">21149426</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1542/peds.2010-1532</pub-id><pub-id pub-id-type="pmcid">PMC3375465</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR84"><label>84.</label><citation-alternatives><element-citation id="ec-CR84" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hafez</surname><given-names>AY</given-names></name><name name-style="western"><surname>Gonzalez</surname><given-names>M</given-names></name><name name-style="western"><surname>Kulik</surname><given-names>MC</given-names></name><name name-style="western"><surname>Vijayaraghavan</surname><given-names>M</given-names></name><name name-style="western"><surname>Glantz</surname><given-names>SA</given-names></name></person-group><article-title>Uneven access to Smoke-Free laws and policies and its effect on health equity in the united states: 2000&#8211;2019</article-title><source>Am J Public Health</source><year>2019</year><volume>109</volume><issue>11</issue><fpage>1568</fpage><lpage>75</lpage><pub-id pub-id-type="pmid">31536405</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2105/AJPH.2019.305289</pub-id><pub-id pub-id-type="pmcid">PMC6775904</pub-id></element-citation><mixed-citation id="mc-CR84" publication-type="journal">Hafez AY, Gonzalez M, Kulik MC, Vijayaraghavan M, Glantz SA. Uneven access to Smoke-Free laws and policies and its effect on health equity in the united states: 2000&#8211;2019. Am J Public Health. 2019;109(11):1568&#8211;75.<pub-id pub-id-type="pmid">31536405</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2105/AJPH.2019.305289</pub-id><pub-id pub-id-type="pmcid">PMC6775904</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR85"><label>85.</label><citation-alternatives><element-citation id="ec-CR85" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Strassmann</surname><given-names>A</given-names></name><name name-style="western"><surname>&#199;olak</surname><given-names>Y</given-names></name><name name-style="western"><surname>Serra-Burriel</surname><given-names>M</given-names></name><name name-style="western"><surname>Nordestgaard</surname><given-names>BG</given-names></name><name name-style="western"><surname>Turk</surname><given-names>A</given-names></name><name name-style="western"><surname>Afzal</surname><given-names>S</given-names></name><etal/></person-group><article-title>Nationwide indoor smoking ban and impact on smoking behaviour and lung function: a two-population natural experiment</article-title><source>Thorax</source><year>2023</year><volume>78</volume><issue>2</issue><fpage>144</fpage><lpage>50</lpage><pub-id pub-id-type="pmid">35277448</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/thoraxjnl-2021-218436</pub-id><pub-id pub-id-type="pmcid">PMC9872239</pub-id></element-citation><mixed-citation id="mc-CR85" publication-type="journal">Strassmann A, &#199;olak Y, Serra-Burriel M, Nordestgaard BG, Turk A, Afzal S, et al. Nationwide indoor smoking ban and impact on smoking behaviour and lung function: a two-population natural experiment. Thorax. 2023;78(2):144&#8211;50.<pub-id pub-id-type="pmid">35277448</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/thoraxjnl-2021-218436</pub-id><pub-id pub-id-type="pmcid">PMC9872239</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR86"><label>86.</label><citation-alternatives><element-citation id="ec-CR86" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Menzies</surname><given-names>D</given-names></name><name name-style="western"><surname>Nair</surname><given-names>A</given-names></name><name name-style="western"><surname>Williamson</surname><given-names>PA</given-names></name><name name-style="western"><surname>Schembri</surname><given-names>S</given-names></name><name name-style="western"><surname>Al-Khairalla</surname><given-names>MZ</given-names></name><name name-style="western"><surname>Barnes</surname><given-names>M</given-names></name><etal/></person-group><article-title>Respiratory symptoms, pulmonary function, and markers of inflammation among bar workers before and after a legislative ban on smoking in public places</article-title><source>JAMA</source><year>2006</year><volume>296</volume><issue>14</issue><fpage>1742</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">17032987</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1001/jama.296.14.1742</pub-id></element-citation><mixed-citation id="mc-CR86" publication-type="journal">Menzies D, Nair A, Williamson PA, Schembri S, Al-Khairalla MZ, Barnes M, et al. Respiratory symptoms, pulmonary function, and markers of inflammation among bar workers before and after a legislative ban on smoking in public places. JAMA. 2006;296(14):1742&#8211;8.<pub-id pub-id-type="pmid">17032987</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1001/jama.296.14.1742</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR87"><label>87.</label><citation-alternatives><element-citation id="ec-CR87" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Humair</surname><given-names>JP</given-names></name><name name-style="western"><surname>Garin</surname><given-names>N</given-names></name><name name-style="western"><surname>Gerstel</surname><given-names>E</given-names></name><name name-style="western"><surname>Carballo</surname><given-names>S</given-names></name><name name-style="western"><surname>Carballo</surname><given-names>D</given-names></name><name name-style="western"><surname>Keller</surname><given-names>PF</given-names></name><etal/></person-group><article-title>Acute respiratory and cardiovascular admissions after a public smoking ban in geneva, Switzerland</article-title><source>PLoS ONE</source><year>2014</year><volume>9</volume><issue>3</issue><fpage>e90417</fpage><pub-id pub-id-type="pmid">24599156</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1371/journal.pone.0090417</pub-id><pub-id pub-id-type="pmcid">PMC3944023</pub-id></element-citation><mixed-citation id="mc-CR87" publication-type="journal">Humair JP, Garin N, Gerstel E, Carballo S, Carballo D, Keller PF, et al. Acute respiratory and cardiovascular admissions after a public smoking ban in geneva, Switzerland. PLoS ONE. 2014;9(3):e90417.<pub-id pub-id-type="pmid">24599156</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1371/journal.pone.0090417</pub-id><pub-id pub-id-type="pmcid">PMC3944023</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR88"><label>88.</label><mixed-citation publication-type="other">Lu W, Aarsand R, Schotte K, Han J, Lebedeva E, Tsoy E, Maglakelidze N, Soriano JB, Bill W, Halpin DMG, Rivera MP, Fong KM, Kathuria H, Yorganc&#305;o&#287;lu A, Gappa M, Lam DC, Rylance S, Sohal SS. Tobacco and COPD: presenting the World Health Organization (WHO) Tobacco Knowledge Summary.Respir Res. 2024 Sep 11;25(1):338. 10.1186/s12931-024-02961-5.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s12931-024-02961-5</pub-id><pub-id pub-id-type="pmcid">PMC11391604</pub-id><pub-id pub-id-type="pmid">39261873</pub-id></mixed-citation></ref><ref id="CR89"><label>89.</label><mixed-citation publication-type="other">A handbook on how to implement mTobaccoCessation: Geneva: World Health Organization and International Telecommunication Union. 2015 [Available from: <ext-link ext-link-type="uri" xlink:href="https://iris.who.int/bitstream/handle/10665/251719/9789241549813-eng.pdf?sequence=1">https://iris.who.int/bitstream/handle/10665/251719/9789241549813-eng.pdf?sequence=1</ext-link></mixed-citation></ref></ref-list></back></article>
        
    </metadata>
</record>
    </GetRecord>

</OAI-PMH>